{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:47:48Z","timestamp":1791881268217,"version":"4.3.4"},"reference-count":279,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"DOI":"10.1007\/s12264-026-01730-2","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:06:40Z","timestamp":1791835600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cystatin C and its Role in the Neuro-Glial-Vascular Unit: Implications for Cerebrovascular Diseases and Neurodegeneration"],"prefix":"10.1007","author":[{"given":"Mingchun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3882-6540","authenticated-orcid":false,"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3310-4442","authenticated-orcid":false,"given":"Xiaobo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"1730_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/0886022X.2020.1757463","volume":"42","author":"I Soveri","year":"2020","unstructured":"Soveri I, Helmersson-Karlqvist J, Fellstr\u00f6m B, Larsson A. Day-to-day variation of the kidney proximal tubular injury markers urinary cystatin C, KIM1, and NGAL in patients with chronic kidney disease. Ren Fail 2020, 42: 400\u2013404.","journal-title":"Ren Fail"},{"key":"1730_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.120016","volume":"565","author":"G Lalmanach","year":"2025","unstructured":"Lalmanach G, Rigoux B, David A, Tahri-Joutey M, Lecaille F, Marchand-Adam S. Human cystatin C in fibrotic diseases. Clin Chim Acta 2025, 565: 120016.","journal-title":"Clin Chim Acta"},{"key":"1730_CR3","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41467-025-56875-x","volume":"16","author":"JM Modenbach","year":"2025","unstructured":"Modenbach JM, M\u00f6ller C, Asgarbeik S, Geist N, Rimkus N, D\u00f6rr M, et al. Biochemical analyses of cystatin-C dimers and cathepsin-B reveals a trypsin-driven feedback mechanism in acute pancreatitis. Nat Commun 2025, 16: 1702.","journal-title":"Nat Commun"},{"key":"1730_CR4","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17252","volume":"12","author":"BE Blancas-Luciano","year":"2024","unstructured":"Blancas-Luciano BE, Becker-Fauser I, Zamora-Chimal J, Jim\u00e9nez-Garc\u00eda L, Lara-Mart\u00ednez R, P\u00e9rez-Torres A, et al. Cystatin C: Immunoregulation role in macrophages infected with Porphyromonas gingivalis. PeerJ 2024, 12: e17252.","journal-title":"PeerJ"},{"key":"1730_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.arr.2016.06.003","volume":"32","author":"PM Mathews","year":"2016","unstructured":"Mathews PM, Levy E. Cystatin C in aging and in Alzheimer\u2019s disease. Ageing Res Rev 2016, 32: 38\u201350.","journal-title":"Ageing Res Rev"},{"key":"1730_CR6","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1080\/07391102.2019.1620636","volume":"38","author":"F Amin","year":"2020","unstructured":"Amin F, Khan MS, Bano B. Mammalian cystatin and protagonists in brain diseases. J Biomol Struct Dyn 2020, 38: 2171\u20132196.","journal-title":"J Biomol Struct Dyn"},{"key":"1730_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41582-022-00703-z","volume":"18","author":"S Tiedt","year":"2022","unstructured":"Tiedt S, Buchan AM, Dichgans M, Lizasoain I, Moro MA, Lo EH. The neurovascular unit and systemic biology in stroke\u2014implications for translation and treatment. Nat Rev Neurol 2022, 18: 597\u2013612.","journal-title":"Nat Rev Neurol"},{"key":"1730_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12264-022-00977-9","volume":"39","author":"D Yao","year":"2023","unstructured":"Yao D, Zhang R, Xie M, Ding F, Wang M, Wang W. Updated understanding of the glial-vascular unit in central nervous system disorders. Neurosci Bull 2023, 39: 503\u2013518.","journal-title":"Neurosci Bull"},{"key":"1730_CR9","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1093\/cercor\/bhab254","volume":"31","author":"E Zisis","year":"2021","unstructured":"Zisis E, Keller D, Kanari L, Arnaudon A, Gevaert M, Delemontex T, et al. Digital reconstruction of the neuro-Glia-vascular architecture. Cereb Cortex 2021, 31: 5686\u20135703.","journal-title":"Cereb Cortex"},{"key":"1730_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.732820","volume":"9","author":"EC Kugler","year":"2021","unstructured":"Kugler EC, Greenwood J, MacDonald RB. The \u201cneuro-glial-vascular\u201d unit: The role of Glia in neurovascular unit formation and dysfunction. Front Cell Dev Biol 2021, 9: 732820.","journal-title":"Front Cell Dev Biol"},{"key":"1730_CR11","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.3390\/cells12222667","volume":"12","author":"D Postnov","year":"2023","unstructured":"Postnov D, Semyachkina-Glushkovskaya O, Litvinenko E, Kurths J, Penzel T. Mechanisms of activation of brain\u2019s drainage during sleep: The nightlife of astrocytes. Cells 2023, 12: 2667.","journal-title":"Cells"},{"key":"1730_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12974-025-03475-7","volume":"22","author":"A Ogaki","year":"2025","unstructured":"Ogaki A, Kinoshita S, Ikegaya Y, Koyama R. Chemokine\u2013complement cascade in glial\u2013vascular units protects neurons from non-biogenic nanoparticles. J Neuroinflammation 2025, 22: 182.","journal-title":"J Neuroinflammation"},{"key":"1730_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122864","volume":"314","author":"G Pavlou","year":"2025","unstructured":"Pavlou G, Spitz S, Pramotton FM, Tsai A, Li BM, Wang X, et al. Engineered 3D human neurovascular model of Alzheimer\u2019s disease to study vascular dysfunction. Biomaterials 2025, 314: 122864.","journal-title":"Biomaterials"},{"key":"1730_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/jnc.14894","volume":"153","author":"B Yang","year":"2020","unstructured":"Yang B, Xu J, Chang L, Miao Z, Heang D, Pu Y, et al. Cystatin C improves blood\u2013brain barrier integrity after ischemic brain injury in mice. J Neurochem 2020, 153: 413\u2013425.","journal-title":"J Neurochem"},{"key":"1730_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.240","volume":"8","author":"J Zou","year":"2017","unstructured":"Zou J, Chen Z, Wei X, Chen Z, Fu Y, Yang X, et al. Cystatin C as a potential therapeutic mediator against Parkinson\u2019s disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units. Cell Death Dis 2017, 8: e2854.","journal-title":"Cell Death Dis"},{"key":"1730_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fnmol.2012.00079","volume":"5","author":"G Kaur","year":"2012","unstructured":"Kaur G, Levy E. Cystatin C in Alzheimer\u2019s disease. Front Mol Neurosci 2012, 5: 79.","journal-title":"Front Mol Neurosci"},{"key":"1730_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2174\/1567202614666171116102504","volume":"14","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Sun L. Cystatin C in cerebrovascular disorders. Curr Neurovasc Res 2017, 14: 406\u2013414.","journal-title":"Curr Neurovasc Res"},{"key":"1730_CR18","doi-asserted-by":"publisher","first-page":"11104","DOI":"10.1038\/s41598-019-47524-7","volume":"9","author":"R P\u00e9rez-Gonz\u00e1lez","year":"2019","unstructured":"P\u00e9rez-Gonz\u00e1lez R, Sahoo S, Gauthier SA, Kim Y, Li M, Kumar A, et al. Neuroprotection mediated by cystatin C-loaded extracellular vesicles. Sci Rep 2019, 9: 11104.","journal-title":"Sci Rep"},{"key":"1730_CR19","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/STROKEAHA.122.036946","volume":"53","author":"E Candelario-Jalil","year":"2022","unstructured":"Candelario-Jalil E, Dijkhuizen RM, Magnus T. Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke 2022, 53: 1473\u20131486.","journal-title":"Stroke"},{"key":"1730_CR20","doi-asserted-by":"publisher","first-page":"2121733","DOI":"10.1155\/2024\/2121733","volume":"2024","author":"ZU Urasheva","year":"2024","unstructured":"Urasheva ZU, Kabdrakhmanova GB, Yermagambetova AP, Utegenova AB, Seitmaganbetova NA, Aliyev OM, et al. Bibliometric analysis of the role of occludin in the pathogenesis of stroke. Oxid Med Cell Longev 2024, 2024: 2121733.","journal-title":"Oxid Med Cell Longev"},{"key":"1730_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2023.104510","volume":"148","author":"L Liu","year":"2023","unstructured":"Liu L, Jiang Y, Steinle JJ. Loss of cystatin C regulates permeability and inflammatory pathways in retina. Microvasc Res 2023, 148: 104510.","journal-title":"Microvasc Res"},{"key":"1730_CR22","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.immuni.2024.05.012","volume":"57","author":"X Ma","year":"2024","unstructured":"Ma X, Lieberman J. Poking holes in the blood-brain barrier. Immunity 2024, 57: 1192\u20131194.","journal-title":"Immunity"},{"key":"1730_CR23","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/jcbfm.2015.170","volume":"35","author":"YH Gu","year":"2015","unstructured":"Gu YH, Kanazawa M, Hung SY, Wang X, Fukuda S, Koziol JA, et al. Cathepsin L acutely alters microvessel integrity within the neurovascular unit during focal cerebral ischemia. J Cereb Blood Flow Metab 2015, 35: 1888\u20131900.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1730_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1021\/acsptsci.0c00217","volume":"4","author":"RC Knopp","year":"2021","unstructured":"Knopp RC, Jastaniah A, Dubrovskyi O, Gaisina I, Tai L, Thatcher GRJ. Extending the calpain-cathepsin hypothesis to the neurovasculature: Protection of brain endothelial cells and mice from neurotrauma. ACS Pharmacol Transl Sci 2021, 4: 372\u2013385.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1730_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110531","volume":"103","author":"H Wang","year":"2023","unstructured":"Wang H, Inoue A, Lei Y, Wu H, Hong L, Cheng XW. Cathepsins in the extracellular space: Focusing on non-lysosomal proteolytic functions with clinical implications. Cell Signal 2023, 103: 110531.","journal-title":"Cell Signal"},{"key":"1730_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/STROKEAHA.116.014975","volume":"48","author":"Z Fang","year":"2017","unstructured":"Fang Z, Deng J, Wu Z, Dong B, Wang S, Chen X, et al. Cystatin C is a crucial endogenous protective determinant against stroke. Stroke 2017, 48: 436\u2013444.","journal-title":"Stroke"},{"key":"1730_CR27","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1091\/mbc.e04-11-1029","volume":"16","author":"E Im","year":"2005","unstructured":"Im E, Venkatakrishnan A, Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell 2005, 16: 3488\u20133500.","journal-title":"Mol Biol Cell"},{"key":"1730_CR28","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.18240\/ijo.2021.09.21","volume":"14","author":"N Yang","year":"2021","unstructured":"Yang N, Lu YF, Yang X, Jiang K, Sang AM, Wu HQ. Association between cystatin C and diabetic retinopathy among type 2 diabetic patients in China: A Meta-analysis. Int J Ophthalmol 2021, 14: 1430\u20131440.","journal-title":"Int J Ophthalmol"},{"key":"1730_CR29","doi-asserted-by":"publisher","first-page":"14799","DOI":"10.1038\/s41598-024-65537-9","volume":"14","author":"S Stuart","year":"2024","unstructured":"Stuart S, Tarade D, Ohh M. Cathepsins L and B target HIF1\u03b1 for oxygen-independent proteolytic cleavage. Sci Rep 2024, 14: 14799.","journal-title":"Sci Rep"},{"key":"1730_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2024.110042","volume":"247","author":"H Yang","year":"2024","unstructured":"Yang H, Han RY, Gong RW, Zhang YJ, Yang SS, Xu GZ, et al. CST3 alleviates retinal vascular leakage by regulating the Rap1 signaling pathway. Exp Eye Res 2024, 247: 110042.","journal-title":"Exp Eye Res"},{"key":"1730_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009167","volume":"7","author":"Z Li","year":"2018","unstructured":"Li Z, Wang S, Huo X, Yu H, Lu J, Zhang S, et al. Cystatin C expression is promoted by VEGFA blocking, with inhibitory effects on endothelial cell angiogenic functions including proliferation, migration, and chorioallantoic membrane angiogenesis. J Am Heart Assoc 2018, 7: e009167.","journal-title":"J Am Heart Assoc"},{"key":"1730_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-vision-112122-020950","volume":"9","author":"JD Zhu","year":"2023","unstructured":"Zhu JD, Tarachand SP, Abdulwahab Q, Samuel MA. Structure, function, and molecular landscapes of the aging retina. Annu Rev Vis Sci 2023, 9: 177\u2013199.","journal-title":"Annu Rev Vis Sci"},{"key":"1730_CR33","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/cells10092394","volume":"10","author":"N Marchesi","year":"2021","unstructured":"Marchesi N, Fahmideh F, Boschi F, Pascale A, Barbieri A. Ocular neurodegenerative diseases: Interconnection between retina and cortical areas. Cells 2021, 10: 2394.","journal-title":"Cells"},{"key":"1730_CR34","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.1007\/s12035-025-04714-x","volume":"62","author":"W Shah","year":"2025","unstructured":"Shah W, Gong Y, Qiao X, Lu Y, Ding Y, Zhang Z, et al. Exploring endothelial cell dysfunction\u2019s impact on the brain-retina microenvironment connection: Molecular mechanisms and implications. Mol Neurobiol 2025, 62: 7484\u20137505.","journal-title":"Mol Neurobiol"},{"key":"1730_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010997","volume":"7","author":"RA Benndorf","year":"2018","unstructured":"Benndorf RA. Renal biomarker and angiostatic mediator? cystatin C as a negative regulator of vascular endothelial cell homeostasis and angiogenesis. J Am Heart Assoc 2018, 7: e010997.","journal-title":"J Am Heart Assoc"},{"key":"1730_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/iovs.61.2.9","volume":"61","author":"E Carlsson","year":"2020","unstructured":"Carlsson E, Supharattanasitthi W, Jackson M, Paraoan L. Increased rate of retinal pigment epithelial cell migration and pro-angiogenic potential ensuing from reduced cystatin C expression. Invest Ophthalmol Vis Sci 2020, 61: 9.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1730_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.tcb.2023.06.001","volume":"34","author":"H van Splunder","year":"2024","unstructured":"van Splunder H, Villacampa P, Mart\u00ednez-Romero A, Graupera M. Pericytes in the disease spotlight. Trends Cell Biol 2024, 34: 58\u201371.","journal-title":"Trends Cell Biol"},{"key":"1730_CR38","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/cells12151931","volume":"12","author":"P Li","year":"2023","unstructured":"Li P, Fan H. Pericyte loss in diseases. Cells 2023, 12: 1931.","journal-title":"Cells"},{"key":"1730_CR39","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1158\/0008-5472.CAN-08-4539","volume":"69","author":"SH Chang","year":"2009","unstructured":"Chang SH, Kanasaki K, Gocheva V, Blum G, Harper J, Moses MA, et al. VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res 2009, 69: 4537\u20134544.","journal-title":"Cancer Res"},{"key":"1730_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114932","volume":"164","author":"A Mustafa","year":"2023","unstructured":"Mustafa A, Elkhamisy F, Arghiani N, Pranjol MZI. Potential crosstalk between pericytes and cathepsins in the tumour microenvironment. Biomed Pharmacother 2023, 164: 114932.","journal-title":"Biomed Pharmacother"},{"key":"1730_CR41","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/01.ATV.0000209518.58252.17","volume":"26","author":"VWM van Hinsbergh","year":"2006","unstructured":"van Hinsbergh VWM, Engelse MA, Quax PHA. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 2006, 26: 716\u2013728.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1730_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102395","volume":"99","author":"S Cunha","year":"2024","unstructured":"Cunha S, Bicker J, Sereno J, Falc\u00e3o A, Fortuna A. Blood brain barrier dysfunction in healthy aging and dementia: Why, how, what for? Ageing Res Rev 2024, 99: 102395.","journal-title":"Ageing Res Rev"},{"key":"1730_CR43","doi-asserted-by":"crossref","unstructured":"Endo F, Kasai A, Soto JS, Yu X, Qu Z, Hashimoto H, et al. Molecular basis of astrocyte diversity and morphology across the CNS in health and disease. Science 2022, 378: eadc9020.","DOI":"10.1126\/science.adc9020"},{"key":"1730_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.brainresbull.2022.08.015","volume":"189","author":"TE Murray","year":"2022","unstructured":"Murray TE, Richards CM, Robert-Gostlin VN, Bernath AK, Lindhout IA, Klegeris A. Potential neurotoxic activity of diverse molecules released by astrocytes. Brain Res Bull 2022, 189: 80\u2013101.","journal-title":"Brain Res Bull"},{"key":"1730_CR45","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3390\/biom11121796","volume":"11","author":"A Pi\u0161lar","year":"2021","unstructured":"Pi\u0161lar A, Bol\u010dina L, Kos J. New insights into the role of cysteine cathepsins in neuroinflammation. Biomolecules 2021, 11: 1796.","journal-title":"Biomolecules"},{"key":"1730_CR46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12017-023-08753-2","volume":"25","author":"LJ Wong","year":"2023","unstructured":"Wong LJ, Lee BWL, Sng YJ, Poh L, Rajeev V, Selvaraji S, et al. Inflammasome activation mediates apoptotic and pyroptotic death in astrocytes under ischemic conditions. Neuromolecular Med 2023, 25: 533\u2013544.","journal-title":"Neuromolecular Med"},{"key":"1730_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/cns.70856","volume":"32","author":"D Wu","year":"2026","unstructured":"Wu D, Ma Y, Wang B, Zheng Y, Ren J, Sun Q, et al. Pathological roles of astrocytes in traumatic brain injury. CNS Neurosci Ther 2026, 32: e70856.","journal-title":"CNS Neurosci Ther"},{"key":"1730_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/15230864251411183","volume":"44","author":"W Lu","year":"2026","unstructured":"Lu W, Jiang Z, Wen J. Rewiring brain recovery: Astrocyte-neuron metabolic cooperation in stroke. Antioxid Redox Signal 2026, 44: 410\u2013435.","journal-title":"Antioxid Redox Signal"},{"key":"1730_CR49","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/STROKEAHA.121.032613","volume":"53","author":"KT Mun","year":"2022","unstructured":"Mun KT, Hinman JD. Inflammation and the link to vascular brain health: Timing is brain. Stroke 2022, 53: 427\u2013436.","journal-title":"Stroke"},{"key":"1730_CR50","doi-asserted-by":"crossref","unstructured":"Lee HG, Lee JH, Flausino LE, Quintana FJ. Neuroinflammation: An astrocyte perspective. Sci Transl Med 2023, 15: eadi7828.","DOI":"10.1126\/scitranslmed.adi7828"},{"key":"1730_CR51","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1093\/brain\/awae085","volume":"147","author":"CG Bergner","year":"2024","unstructured":"Bergner CG, Breur M, Soto-Bernardini MC, Sch\u00e4fer L, Lier J, Le Duc D, et al. Dominant CST3 variants cause adult onset leukodystrophy without amyloid angiopathy. Brain 2024, 147: 3562\u20133572.","journal-title":"Brain"},{"key":"1730_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1471-4159.2006.04169.x","volume":"100","author":"A Hasegawa","year":"2007","unstructured":"Hasegawa A, Naruse M, Hitoshi S, Iwasaki Y, Takebayashi H, Ikenaka K. Regulation of glial development by cystatin C. J Neurochem 2007, 100: 12\u201322.","journal-title":"J Neurochem"},{"key":"1730_CR53","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3390\/cells10082071","volume":"10","author":"M Biasizzo","year":"2021","unstructured":"Biasizzo M, Trstenjak-Prebanda M, Dolinar K, Pirkmajer S, Zavr\u0161nik J, Turk B, et al. Cystatin C deficiency increases LPS-induced sepsis and NLRP3 inflammasome activation in mice. Cells 2021, 10: 2071.","journal-title":"Cells"},{"key":"1730_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2025.110152","volume":"148","author":"J Chen","year":"2026","unstructured":"Chen J, Lian H, Guo R, Chen K, Ma H, Yang J, et al. Multi-omics analysis of ketogenic diet-mediated neural repair in spinal cord injury: Targeting of lysosomal autophagy through CTSB\/LAMP2 regulation. J Nutr Biochem 2026, 148: 110152.","journal-title":"J Nutr Biochem"},{"key":"1730_CR55","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202403101R","volume":"39","author":"H Zhang","year":"2025","unstructured":"Zhang H, Qin X, Yuan H, Xiang L, Yu H. Cathepsin L aggravates neuroinflammation via promoting microglia M1 polarization and NLRP3 activation after spinal cord injury. FASEB J 2025, 39: e70561.","journal-title":"FASEB J"},{"key":"1730_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70037","volume":"169","author":"HL Shih","year":"2025","unstructured":"Shih HL, Cheng KH, Chen CH, Chang JY, Hsu KS. Upregulation of cathepsin S expression contributes to neuronal damage following kainic acid\u2013induced status epilepticus. J Neurochem 2025, 169: e70037.","journal-title":"J Neurochem"},{"key":"1730_CR57","doi-asserted-by":"publisher","first-page":"9646","DOI":"10.1007\/s12035-024-04195-4","volume":"61","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Dong W, Wang L, Ren S, Wei W, Wu G. Cystatin C attenuates perihematomal secondary brain injury by inhibiting the cathepsin B\/NLRP3 signaling pathway in a rat model of intracerebral hemorrhage. Mol Neurobiol 2024, 61: 9646\u20139662.","journal-title":"Mol Neurobiol"},{"key":"1730_CR58","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/17460441.2024.2335210","volume":"19","author":"I Lepiarz-Raba","year":"2024","unstructured":"Lepiarz-Raba I, Hidayat T, Hannan AJ, Jawaid A. Potential Alzheimer\u2019s disease drug targets identified through microglial biology research. Expert Opin Drug Discov 2024, 19: 587\u2013602.","journal-title":"Expert Opin Drug Discov"},{"key":"1730_CR59","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: Mechanism and potential therapeutic targets. Signal Transduct Target Ther 2023, 8: 359.","journal-title":"Signal Transduct Target Ther"},{"key":"1730_CR60","doi-asserted-by":"publisher","first-page":"2412184","DOI":"10.1002\/advs.202412184","volume":"12","author":"J Pan","year":"2025","unstructured":"Pan J, Zhong J, Geng J, Oberhauser J, Shi S, Wan J. Microglial Lyzl4 facilitates \u03b2-amyloid clearance in Alzheimer\u2019s disease. Adv Sci 2025, 12: 2412184.","journal-title":"Adv Sci"},{"key":"1730_CR61","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41386-024-01994-0","volume":"50","author":"M Jiang","year":"2025","unstructured":"Jiang M, Zhao D, Zhou Y, Kong W, Xie Z, Xiong Y, et al. Cathepsin B modulates microglial migration and phagocytosis of amyloid \u03b2 in Alzheimer\u2019s disease through PI3K-Akt signaling. Neuropsychopharmacology 2025, 50: 640\u2013650.","journal-title":"Neuropsychopharmacology"},{"key":"1730_CR62","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/s41593-023-01423-3","volume":"26","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Czopka T. Myelination-independent functions of oligodendrocyte precursor cells in health and disease. Nat Neurosci 2023, 26: 1663\u20131669.","journal-title":"Nat Neurosci"},{"key":"1730_CR63","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11064-006-9183-y","volume":"32","author":"J Ma","year":"2007","unstructured":"Ma J, Tanaka KF, Yamada G, Ikenaka K. Induced expression of cathepsins and cystatin C in a murine model of demyelination. Neurochem Res 2007, 32: 311\u2013320.","journal-title":"Neurochem Res"},{"key":"1730_CR64","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1111\/j.1582-4934.2010.01229.x","volume":"15","author":"D Haves-Zburof","year":"2011","unstructured":"Haves-Zburof D, Paperna T, Gour-Lavie A, Mandel I, Glass-Marmor L, Miller A. Cathepsins and their endogenous inhibitors cystatins: Expression and modulation in multiple sclerosis. J Cell Mol Med 2011, 15: 2421\u20132429.","journal-title":"J Cell Mol Med"},{"key":"1730_CR65","doi-asserted-by":"publisher","first-page":"12637","DOI":"10.3390\/ijms252312637","volume":"25","author":"O Perdaens","year":"2024","unstructured":"Perdaens O, van Pesch V. Should we consider neurodegeneration by itself or in a triangulation with neuroinflammation and demyelination? the example of multiple sclerosis and beyond. Int J Mol Sci 2024, 25: 12637.","journal-title":"Int J Mol Sci"},{"key":"1730_CR66","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.imlet.2018.01.006","volume":"196","author":"M Zi","year":"2018","unstructured":"Zi M, Xu Y. Involvement of cystatin C in immunity and apoptosis. Immunol Lett 2018, 196: 80\u201390.","journal-title":"Immunol Lett"},{"key":"1730_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2023.108804","volume":"138","author":"YK Kodagoda","year":"2023","unstructured":"Kodagoda YK, Liyanage DS, Omeka WKM, Kim G, Kim J, Lee J. Identification, expression profiling, and functional characterization of cystatin C from big-belly seahorse (Hippocampus abdominalis). Fish Shellfish Immunol 2023, 138: 108804.","journal-title":"Fish Shellfish Immunol"},{"key":"1730_CR68","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2014.04.052","volume":"158","author":"TJ Yuen","year":"2014","unstructured":"Yuen TJ, Silbereis JC, Griveau A, Chang SM, Daneman R, Fancy SPJ, et al. Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell 2014, 158: 383\u2013396.","journal-title":"Cell"},{"key":"1730_CR69","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5114\/aoms\/171706","volume":"20","author":"B Sta\u0144czykiewicz","year":"2023","unstructured":"Sta\u0144czykiewicz B, \u0141uc M, Banach M, Zab\u0142ocka A. Cystatins: Unravelling the biological implications for neuroprotection. Arch Med Sci 2023, 20: 157\u2013166.","journal-title":"Arch Med Sci"},{"key":"1730_CR70","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.2353\/ajpath.2010.100829","volume":"177","author":"L D\u2019Adamio","year":"2010","unstructured":"D\u2019Adamio L. Role of cystatin C in neuroprotection and its therapeutic implications. Am J Pathol 2010, 177: 2163\u20132165.","journal-title":"Am J Pathol"},{"key":"1730_CR71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.arr.2016.04.010","volume":"32","author":"V Stoka","year":"2016","unstructured":"Stoka V, Turk V, Turk B. Lysosomal cathepsins and their regulation in aging and neurodegeneration. Ageing Res Rev 2016, 32: 22\u201337.","journal-title":"Ageing Res Rev"},{"key":"1730_CR72","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.biochi.2024.04.010","volume":"226","author":"U Pe\u010dar Fonovi\u0107","year":"2024","unstructured":"Pe\u010dar Fonovi\u0107 U, Kos J, Mitrovi\u0107 A. Compensational role between cathepsins. Biochimie 2024, 226: 62\u201376.","journal-title":"Biochimie"},{"key":"1730_CR73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0197-4580(03)00034-4","volume":"25","author":"B Boland","year":"2004","unstructured":"Boland B, Campbell V. Abeta-mediated activation of the apoptotic cascade in cultured cortical neurones: A role for cathepsin-L. Neurobiol Aging 2004, 25: 83\u201391.","journal-title":"Neurobiol Aging"},{"key":"1730_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13531","volume":"21","author":"MI Islam","year":"2022","unstructured":"Islam MI, Nagakannan P, Shcholok T, Contu F, Mai S, Albensi BC, et al. Regulatory role of cathepsin L in induction of nuclear laminopathy in Alzheimer\u2019s disease. Aging Cell 2022, 21: e13531.","journal-title":"Aging Cell"},{"key":"1730_CR75","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.2741\/3089","volume":"13","author":"V Turk","year":"2008","unstructured":"Turk V, Stoka V, Turk D. Cystatins: Biochemical and structural properties, and medical relevance. Front Biosci 2008, 13: 5406\u20135420.","journal-title":"Front Biosci"},{"key":"1730_CR76","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0167-4838(99)00263-0","volume":"1477","author":"B Turk","year":"2000","unstructured":"Turk B, Turk D, Turk V. Lysosomal cysteine proteases: More than scavengers. Biochim Biophys Acta 2000, 1477: 98\u2013111.","journal-title":"Biochim Biophys Acta"},{"key":"1730_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119243","volume":"1869","author":"A Drobny","year":"2022","unstructured":"Drobny A, Prieto Huarcaya S, Dobert J, Kluge A, Bunk J, Schlothauer T, et al. The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches. Biochim Biophys Acta BBA Mol Cell Res 2022, 1869: 119243.","journal-title":"Biochim Biophys Acta BBA Mol Cell Res"},{"key":"1730_CR78","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1046\/j.1471-4159.2001.00146.x","volume":"76","author":"PJ Kingham","year":"2001","unstructured":"Kingham PJ, Pocock JM. Microglial secreted cathepsin B induces neuronal apoptosis. J Neurochem 2001, 76: 1475\u20131484.","journal-title":"J Neurochem"},{"key":"1730_CR79","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s13365-015-0358-7","volume":"21","author":"F Zen\u00f3n","year":"2015","unstructured":"Zen\u00f3n F, Cantres-Rosario Y, Adiga R, Gonzalez M, Rodriguez-Franco E, Langford D, et al. HIV-infected microglia mediate cathepsin B-induced neurotoxicity. J Neurovirol 2015, 21: 544\u2013558.","journal-title":"J Neurovirol"},{"key":"1730_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119383","volume":"1870","author":"MS Hossain","year":"2023","unstructured":"Hossain MS, Ramasamy VS, Park IS. Involvement of calcium ions in amyloid-\u03b2-induced lamin fragmentation. Biochim Biophys Acta Mol Cell Res 2023, 1870: 119383.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1730_CR81","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00418-024-02331-8","volume":"163","author":"MS Hossain","year":"2024","unstructured":"Hossain MS, Haque MA, Park IS. Novel role of curcumin as inhibitor of \u03b2-amyloid-induced lamin fragmentation. Histochem Cell Biol 2024, 163: 2.","journal-title":"Histochem Cell Biol"},{"key":"1730_CR82","first-page":"541","volume":"3","author":"S Gauthier","year":"2011","unstructured":"Gauthier S, Kaur G, Mi W, Tizon B, Levy E. Protective mechanisms by cystatin C in neurodegenerative diseases. Front Biosci 2011, 3: 541\u2013554.","journal-title":"Front Biosci"},{"key":"1730_CR83","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.7150\/thno.55645","volume":"11","author":"M Wang","year":"2021","unstructured":"Wang M, Xu Y, Zhang Y, Chen Y, Chang G, An G, et al. Deciphering the autophagy regulatory network via single-cell transcriptome analysis reveals a requirement for autophagy homeostasis in spermatogenesis. Theranostics 2021, 11: 5010\u20135027.","journal-title":"Theranostics"},{"key":"1730_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.459","volume":"5","author":"S Watanabe","year":"2014","unstructured":"Watanabe S, Hayakawa T, Wakasugi K, Yamanaka K. Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity. Cell Death Dis 2014, 5: e1497.","journal-title":"Cell Death Dis"},{"key":"1730_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009819","volume":"5","author":"B Tizon","year":"2010","unstructured":"Tizon B, Sahoo S, Yu H, Gauthier S, Kumar AR, Mohan P, et al. Induction of autophagy by cystatin C: A mechanism that protects murine primary cortical neurons and neuronal cell lines. PLoS One 2010, 5: e9819.","journal-title":"PLoS One"},{"key":"1730_CR86","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/jnc.14285","volume":"145","author":"S Watanabe","year":"2018","unstructured":"Watanabe S, Komine O, Endo F, Wakasugi K, Yamanaka K. Intracerebroventricular administration of Cystatin C ameliorates disease in SOD1-linked amyotrophic lateral sclerosis mice. J Neurochem 2018, 145: 80\u201389.","journal-title":"J Neurochem"},{"key":"1730_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2025.100053","volume":"77","author":"Y Fu","year":"2025","unstructured":"Fu Y, Zhang J, Qin R, Ren Y, Zhou T, Han B, et al. Activating autophagy to eliminate toxic protein aggregates with small molecules in neurodegenerative diseases. Pharmacol Rev 2025, 77: 100053.","journal-title":"Pharmacol Rev"},{"key":"1730_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189342","volume":"1880","author":"PK Senapati","year":"2025","unstructured":"Senapati PK, Mahapatra KK, Singh A, Bhutia SK. mTOR inhibitors in targeting autophagy and autophagy-associated signaling for cancer cell death and therapy. Biochim Biophys Acta BBA Rev Cancer 2025, 1880: 189342.","journal-title":"Biochim Biophys Acta BBA Rev Cancer"},{"key":"1730_CR89","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41580-025-00873-w","volume":"27","author":"M Radulovic","year":"2026","unstructured":"Radulovic M, Yang C, Stenmark H. Lysosomal membrane homeostasis and its importance in physiology and disease. Nat Rev Mol Cell Biol 2026, 27: 71\u201387.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1730_CR90","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nyas.14305","volume":"1467","author":"MAA Al-Bari","year":"2020","unstructured":"Al-Bari MAA, Xu P. Molecular regulation of autophagy machinery by mTOR-dependent and-independent pathways. Ann N Y Acad Sci 2020, 1467: 3\u201320.","journal-title":"Ann N Y Acad Sci"},{"key":"1730_CR91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2024.09.015","volume":"113","author":"JE Palmer","year":"2025","unstructured":"Palmer JE, Wilson N, Son SM, Obrocki P, Wrobel L, Rob M, et al. Autophagy, aging, and age-related neurodegeneration. Neuron 2025, 113: 29\u201348.","journal-title":"Neuron"},{"key":"1730_CR92","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1080\/15548627.2023.2165313","volume":"19","author":"S Beccari","year":"2023","unstructured":"Beccari S, Sierra-Torre V, Valero J, Pereira-Iglesias M, Garc\u00eda-Zaballa M, Soria FN, et al. Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy. Autophagy 2023, 19: 1952\u20131981.","journal-title":"Autophagy"},{"key":"1730_CR93","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","volume":"25","author":"RA Nixon","year":"2024","unstructured":"Nixon RA, Rubinsztein DC. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat Rev Mol Cell Biol 2024, 25: 926\u2013946.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1730_CR94","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00018-024-05266-4","volume":"81","author":"Y Gui","year":"2024","unstructured":"Gui Y, Kim Y, Brenna S, Wilmes M, Zaghen G, Goulbourne CN, et al. Cystatin C loaded in brain-derived extracellular vesicles rescues synapses after ischemic insult in vitro and in vivo. Cell Mol Life Sci 2024, 81: 224.","journal-title":"Cell Mol Life Sci"},{"key":"1730_CR95","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1080\/15548627.2020.1840796","volume":"17","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wei M, Fan J, Yan W, Zha X, Song H, et al. Ischemia-induced upregulation of autophagy preludes dysfunctional lysosomal storage and associated synaptic impairments in neurons. Autophagy 2021, 17: 1519\u20131542.","journal-title":"Autophagy"},{"key":"1730_CR96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/1673-5374.286948","volume":"16","author":"AP Tran","year":"2021","unstructured":"Tran AP, Silver J. Cathepsins in neuronal plasticity. Neural Regen Res 2021, 16: 26\u201335.","journal-title":"Neural Regen Res"},{"key":"1730_CR97","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.tins.2023.08.001","volume":"46","author":"SA Connor","year":"2023","unstructured":"Connor SA, Siddiqui TJ. Synapse organizers as molecular codes for synaptic plasticity. Trends Neurosci 2023, 46: 971\u2013985.","journal-title":"Trends Neurosci"},{"key":"1730_CR98","doi-asserted-by":"crossref","unstructured":"Goel F, Singh P, Rai SN, Yadav DK. Neuropharmacology of synaptic plasticity: Pathways to cognitive resilience in healthy aging. 3 Biotech 2026, 16: 64.","DOI":"10.1007\/s13205-025-04673-z"},{"key":"1730_CR99","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/ng.2007.29","volume":"39","author":"W Mi","year":"2007","unstructured":"Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, et al. Cystatin C inhibits amyloid-\u03b2 deposition in Alzheimer\u2019s disease mouse models. Nat Genet 2007, 39: 1440\u20131442.","journal-title":"Nat Genet"},{"key":"1730_CR100","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0896-6273(00)00119-7","volume":"28","author":"P Taupin","year":"2000","unstructured":"Taupin P, Ray J, Fischer WH, Suhr ST, Hakansson K, Grubb A, et al. FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine\/paracrine cofactor. Neuron 2000, 28: 385\u2013397.","journal-title":"Neuron"},{"key":"1730_CR101","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.nbd.2005.03.006","volume":"20","author":"TJ Pirttil\u00e4","year":"2005","unstructured":"Pirttil\u00e4 TJ, Lukasiuk K, H\u00e5kansson K, Grubb A, Abrahamson M, Pitk\u00e4nen A. Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse. Neurobiol Dis 2005, 20: 241\u2013253.","journal-title":"Neurobiol Dis"},{"key":"1730_CR102","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1073\/pnas.0509789103","volume":"103","author":"T Kato","year":"2006","unstructured":"Kato T, Heike T, Okawa K, Haruyama M, Shiraishi K, Yoshimoto M, et al. A neurosphere-derived factor, cystatin C, supports differentiation of ES cells into neural stem cells. Proc Natl Acad Sci U S A 2006, 103: 6019\u20136024.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1730_CR103","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1471-4159.2012.07826.x","volume":"122","author":"G Dutta","year":"2012","unstructured":"Dutta G, Barber DS, Zhang P, Doperalski NJ, Liu B. Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity. J Neurochem 2012, 122: 752\u2013763.","journal-title":"J Neurochem"},{"key":"1730_CR104","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.nbd.2004.08.012","volume":"18","author":"L Xu","year":"2005","unstructured":"Xu L, Sheng J, Tang Z, Wu X, Yu Y, Guo H, et al. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Neurobiol Dis 2005, 18: 152\u2013165.","journal-title":"Neurobiol Dis"},{"key":"1730_CR105","doi-asserted-by":"crossref","unstructured":"Sanjay, Sood R, Jaiswal V, Kang SU, Park M, Lee HJ. Nobiletin regulates intracellular Ca2+ levels via IP(3)R and ameliorates neuroinflammation in A\u03b242-induced astrocytes. Redox Biol 2024, 73: 103197.","DOI":"10.1016\/j.redox.2024.103197"},{"key":"1730_CR106","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","volume":"19","author":"A Heidari","year":"2022","unstructured":"Heidari A, Yazdanpanah N, Rezaei N. The role of Toll-like receptors and neuroinflammation in Parkinson\u2019s disease. J Neuroinflammation 2022, 19: 135.","journal-title":"J Neuroinflammation"},{"key":"1730_CR107","doi-asserted-by":"publisher","first-page":"11995","DOI":"10.3390\/ijms262411995","volume":"26","author":"E Ahremenko","year":"2025","unstructured":"Ahremenko E, Andreev A, Apushkin D, Korkotian E. Glial cells in the early stages of neurodegeneration: Pathogenesis and therapeutic targets. Int J Mol Sci 2025, 26: 11995.","journal-title":"Int J Mol Sci"},{"key":"1730_CR108","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40035-024-00448-3","volume":"13","author":"F Weiss","year":"2024","unstructured":"Weiss F, Hughes L, Fu Y, Bardy C, Halliday GM, Dzamko N. Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson\u2019s model. Transl Neurodegener 2024, 13: 62.","journal-title":"Transl Neurodegener"},{"key":"1730_CR109","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammation 2022, 19: 206.","journal-title":"J Neuroinflammation"},{"key":"1730_CR110","doi-asserted-by":"crossref","unstructured":"Rajani RM, Quick S, Ruigrok SR, Graham D, Harris SE, Verhaaren BFJ, et al. Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats. Sci Transl Med 2018, 10: eaam9507.","DOI":"10.1126\/scitranslmed.aam9507"},{"key":"1730_CR111","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1046\/j.1460-9568.1998.00184.x","volume":"10","author":"T Yamashima","year":"1998","unstructured":"Yamashima T, Kohda Y, Tsuchiya K, Ueno T, Yamashita J, Yoshioka T, et al. Inhibition of ischaemic hippocampal neuronal death in Primates with cathepsin B inhibitor CA-074: A novel strategy for neuroprotection based on \u2018calpain-cathepsin hypothesis.\u2019 Eur J Neurosci 1998, 10: 1723\u20131733.","journal-title":"Eur J Neurosci"},{"key":"1730_CR112","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2004.06.024","volume":"128","author":"T Olsson","year":"2004","unstructured":"Olsson T, Nygren J, H\u00e5kansson K, Lundblad C, Grubb A, Smith ML, et al. Gene deletion of cystatin C aggravates brain damage following focal ischemia but mitigates the neuronal injury after global ischemia in the mouse. Neuroscience 2004, 128: 65\u201371.","journal-title":"Neuroscience"},{"key":"1730_CR113","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","volume":"350","author":"B Sethi","year":"2022","unstructured":"Sethi B, Kumar V, Mahato K, Coulter DW, Mahato RI. Recent advances in drug delivery and targeting to the brain. J Control Release 2022, 350: 668\u2013687.","journal-title":"J Control Release"},{"key":"1730_CR114","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.2174\/1570159X1812201102145717","volume":"18","author":"Q Hu","year":"2020","unstructured":"Hu Q, Manaenko A. Blood-brain barrier dysfunction in cerebrovascular diseases. Curr Neuropharmacol 2020, 18: 1166\u20131167.","journal-title":"Curr Neuropharmacol"},{"key":"1730_CR115","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2174\/1570159X18666200620230321","volume":"18","author":"Y Huang","year":"2020","unstructured":"Huang Y, Chen S, Luo Y, Han Z. Crosstalk between inflammation and the BBB in stroke. Curr Neuropharmacol 2020, 18: 1227\u20131236.","journal-title":"Curr Neuropharmacol"},{"key":"1730_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2020.140465","volume":"1868","author":"H Nakanishi","year":"2020","unstructured":"Nakanishi H. Cathepsin regulation on microglial function. Biochim Biophys Acta Proteins Proteom 2020, 1868: 140465.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"1730_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111532","volume":"41","author":"S Li","year":"2022","unstructured":"Li S, Fang Y, Zhang Y, Song M, Zhang X, Ding X, et al. Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like mice. Cell Rep 2022, 41: 111532.","journal-title":"Cell Rep"},{"key":"1730_CR118","doi-asserted-by":"crossref","unstructured":"Chen X, Huang X, An Y, Gao C, Gao Y, Shan H, et al. Snapin mediates neuronal PANoptosis after mild traumatic brain injury via H2S-dependent S-sulfhydration of CTSD. J Adv Res 2026, pii: S2090-1232(26)00064-0.","DOI":"10.1016\/j.jare.2026.01.039"},{"key":"1730_CR119","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.043416","volume":"14","author":"Y Liang","year":"2025","unstructured":"Liang Y, Zhao D, Wu PF, Liang YQ, Zhang XW, Xing J, et al. Circulating cathepsin D exacerbates injury-induced brain damage by promoting neutrophil infiltration into the brain. J Am Heart Assoc 2025, 14: e043416.","journal-title":"J Am Heart Assoc"},{"key":"1730_CR120","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/08923973.2024.2444956","volume":"47","author":"Z Montazeri-Khosh","year":"2025","unstructured":"Montazeri-Khosh Z, Ebrahimpour A, Keshavarz M, Sheybani-Arani M, Samiei A. Combination therapies and other therapeutic approaches targeting the NLRP3 inflammasome and neuroinflammatory pathways: A promising approach for traumatic brain injury. Immunopharmacol Immunotoxicol 2025, 47: 159\u2013175.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1730_CR121","doi-asserted-by":"publisher","first-page":"456","DOI":"10.2353\/ajpath.2010.090381","volume":"177","author":"S Schulte","year":"2010","unstructured":"Schulte S, Sun J, Libby P, MacFarlane L, Sun C, Lopez-Ilasaca M, et al. Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice. Am J Pathol 2010, 177: 456\u2013463.","journal-title":"Am J Pathol"},{"key":"1730_CR122","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s12035-024-04290-6","volume":"62","author":"L Xiang","year":"2025","unstructured":"Xiang L, Lou J, Zhao J, Geng Y, Zhang J, Wu Y, et al. Underlying mechanism of lysosomal membrane permeabilization in CNS injury: A literature review. Mol Neurobiol 2025, 62: 626\u2013642.","journal-title":"Mol Neurobiol"},{"key":"1730_CR123","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/exnr.1998.6988","volume":"155","author":"K Tsuchiya","year":"1999","unstructured":"Tsuchiya K, Kohda Y, Yoshida M, Zhao L, Ueno T, Yamashita J, et al. Postictal blockade of ischemic hippocampal neuronal death in Primates using selective cathepsin inhibitors. Exp Neurol 1999, 155: 187\u2013194.","journal-title":"Exp Neurol"},{"key":"1730_CR124","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-002-0554-4","volume":"104","author":"M Yoshida","year":"2002","unstructured":"Yoshida M, Yamashima T, Zhao L, Tsuchiya K, Kohda Y, Tonchev AB, et al. Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathol 2002, 104: 267\u2013272.","journal-title":"Acta Neuropathol"},{"key":"1730_CR125","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/acschembio.5c00463","volume":"20","author":"V Hook","year":"2025","unstructured":"Hook V, Podvin S, Yoon MC, Phan VV, Florio J, Spencer B, et al. Neutral pH-selective inhibition of cytosolic cathepsin B: A novel drug targeting strategy for traumatic brain injury and Alzheimer\u2019s disease. ACS Chem Biol 2025, 20: 1841\u20131848.","journal-title":"ACS Chem Biol"},{"key":"1730_CR126","doi-asserted-by":"publisher","first-page":"1581711","DOI":"10.3389\/fmolb.2025.1581711","volume":"12","author":"N Hassan","year":"2025","unstructured":"Hassan N, Furkan M, Khan MS, Zuberi A, Shahwan M, Shamsi A. Structure-guided virtual screening reveals phytoconstituents as potent cathepsin B inhibitors: Implications for cancer, traumatic brain injury, and Alzheimer\u2019s disease. Front Mol Biosci 2025, 12: 1581711.","journal-title":"Front Mol Biosci"},{"key":"1730_CR127","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1021\/acschemneuro.4c00577","volume":"16","author":"S Podvin","year":"2025","unstructured":"Podvin S, Florio J, Spencer B, Mante M, Guzman E, Arias C, et al. Activation of cytosolic cathepsin B activity in the brain by traumatic brain injury and inhibition by the neutral pH selective inhibitor probe Z-arg-Lys-AOMK. ACS Chem Neurosci 2025, 16: 1297\u20131308.","journal-title":"ACS Chem Neurosci"},{"key":"1730_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114347","volume":"363","author":"J Peng","year":"2023","unstructured":"Peng J, Gao C, Chen X, Wang T, Luo C, Zhang M, et al. Ruxolitinib, a promising therapeutic candidate for traumatic brain injury through maintaining the homeostasis of cathepsin B. Exp Neurol 2023, 363: 114347.","journal-title":"Exp Neurol"},{"key":"1730_CR129","doi-asserted-by":"publisher","DOI":"10.2174\/011570159X399036251124052750","author":"R Meng","year":"2026","unstructured":"Meng R, Zhong X, Zhang S, Qiu Y, Quan Z, Qing H, et al. Cathepsins in ischemic stroke: Unveiling neuropharmacological roles and therapeutic potential. Curr Neuropharmacol 2026, https:\/\/doi.org\/10.2174\/011570159X399036251124052750.","journal-title":"Curr Neuropharmacol"},{"key":"1730_CR130","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s40001-026-03840-z","volume":"31","author":"L Luo","year":"2026","unstructured":"Luo L, Qiao S. Neuroinflammation and blood\u2013brain barrier dysfunction in cerebral small vessel disease: Mechanisms, biomarkers, and therapeutic implications. Eur J Med Res 2026, 31: 307.","journal-title":"Eur J Med Res"},{"key":"1730_CR131","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214711","volume":"106","author":"Z Zhang","year":"2026","unstructured":"Zhang Z, Zhang D, Cai X, Yang Y, Sun J, Niu G, et al. Association of systemic inflammatory markers with cerebral small vessel disease progression: A community-based prospective study. Neurology 2026, 106: e214711.","journal-title":"Neurology"},{"key":"1730_CR132","doi-asserted-by":"publisher","first-page":"11494","DOI":"10.3390\/ijms262311494","volume":"26","author":"K Ishikawa","year":"2025","unstructured":"Ishikawa K, Fujikawa R, Okita K, Kimura F, Watanabe T, Katsurabayashi S, et al. Microglia in brain aging and age-related diseases: Friends or foes? Int J Mol Sci 2025, 26: 11494.","journal-title":"Int J Mol Sci"},{"key":"1730_CR133","doi-asserted-by":"publisher","first-page":"1804207","DOI":"10.3389\/fimmu.2026.1804207","volume":"17","author":"C He","year":"2026","unstructured":"He C, Shi H, Yu Z, Jiao Z, Li J, Yang F. Reprogramming microglia in sepsis-associated encephalopathy: From pathological dysfunction to therapeutic restoration. Front Immunol 2026, 17: 1804207.","journal-title":"Front Immunol"},{"key":"1730_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2026.106293","volume":"133","author":"M Knoop","year":"2026","unstructured":"Knoop M, Trak E, Possovre ML, van de Looij Y, Schirmbeck G, Ceyz\u00e9riat K, et al. Chemogenetic activation of oxytocinergic neurons modulates acute neuroinflammation and improves brain development after pediatric traumatic brain injury. Brain Behav Immun 2026, 133: 106293.","journal-title":"Brain Behav Immun"},{"key":"1730_CR135","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature 2021, 592: 524\u2013533.","journal-title":"Nature"},{"key":"1730_CR136","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/ATVBAHA.123.319932","volume":"44","author":"K Kawai","year":"2024","unstructured":"Kawai K, Finn AV, Virmani R, Garg P, Bhatia H, Allen T, et al. Subclinical atherosclerosis: Part 1: What is it? can it be defined at the histological level? Arterioscler Thromb Vasc Biol 2024, 44: 12\u201323.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1730_CR137","doi-asserted-by":"publisher","first-page":"474","DOI":"10.5551\/jat.ED140","volume":"28","author":"S Sawada","year":"2021","unstructured":"Sawada S. Cystatin C as a promising biomarker of atherosclerotic plaque. J Atheroscler Thromb 2021, 28: 474\u2013476.","journal-title":"J Atheroscler Thromb"},{"key":"1730_CR138","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1161\/01.RES.0000155964.34150.F7","volume":"96","author":"GK Sukhova","year":"2005","unstructured":"Sukhova GK, Wang B, Libby P, Pan JH, Zhang Y, Grubb A, et al. Cystatin C deficiency increases elastic Lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 2005, 96: 368\u2013375.","journal-title":"Circ Res"},{"key":"1730_CR139","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s44161-024-00569-y","volume":"3","author":"A Lin","year":"2024","unstructured":"Lin A, Miano JM, Fisher EA, Misra A. Chronic inflammation and vascular cell plasticity in atherosclerosis. Nat Cardiovasc Res 2024, 3: 1408\u20131423.","journal-title":"Nat Cardiovasc Res"},{"key":"1730_CR140","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijcard.2019.09.070","volume":"298","author":"Y Lu","year":"2020","unstructured":"Lu Y, Sun X, Peng L, Jiang W, Li W, Yuan H, et al. Angiotensin II-Induced vascular remodeling and hypertension involves cathepsin L\/V- MEK\/ERK mediated mechanism. Int J Cardiol 2020, 298: 98\u2013106.","journal-title":"Int J Cardiol"},{"key":"1730_CR141","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2353\/ajpath.2006.050295","volume":"168","author":"XW Cheng","year":"2006","unstructured":"Cheng XW, Kuzuya M, Nakamura K, Di Q, Liu Z, Sasaki T, et al. Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin \u03b1\u03bd\u03b23. Am J Pathol 2006, 168: 685\u2013694.","journal-title":"Am J Pathol"},{"key":"1730_CR142","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1007\/s00415-023-11631-3","volume":"270","author":"BE Schroeder","year":"2023","unstructured":"Schroeder BE, Robertson NP, Hughes TAT. Cerebral amyloid angiopathy: An update. J Neurol 2023, 270: 2809\u20132811.","journal-title":"J Neurol"},{"key":"1730_CR143","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1474-4422(23)00114-X","volume":"22","author":"EA Koemans","year":"2023","unstructured":"Koemans EA, Chhatwal JP, van Veluw SJ, van Etten ES, van Osch MJP, van Walderveen MAA, et al. Progression of cerebral amyloid angiopathy: A pathophysiological framework. Lancet Neurol 2023, 22: 632\u2013642.","journal-title":"Lancet Neurol"},{"key":"1730_CR144","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease\u2014one peptide, two pathways. Nat Rev Neurol 2020, 16: 30\u201342.","journal-title":"Nat Rev Neurol"},{"key":"1730_CR145","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13291","volume":"35","author":"AO Snorradottir","year":"2025","unstructured":"Snorradottir AO, Hakonarson H, Palsdottir A. The historical background of hereditary cystatin C amyloid angiopathy: Genealogical, pathological, and clinical manifestations. Brain Pathol 2025, 35: e13291.","journal-title":"Brain Pathol"},{"key":"1730_CR146","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1750-3639.2006.tb00562.x","volume":"16","author":"E Levy","year":"2006","unstructured":"Levy E, Jaskolski M, Grubb A. The role of cystatin C in cerebral amyloid angiopathy and stroke: Cell biology and animal models. Brain Pathol 2006, 16: 60\u201370.","journal-title":"Brain Pathol"},{"key":"1730_CR147","doi-asserted-by":"publisher","first-page":"11485","DOI":"10.1074\/jbc.M117.786558","volume":"292","author":"TJ Perlenfein","year":"2017","unstructured":"Perlenfein TJ, Mehlhoff JD, Murphy RM. Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with \u03b2-amyloid. J Biol Chem 2017, 292: 11485\u201311498.","journal-title":"J Biol Chem"},{"key":"1730_CR148","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1038\/s41467-021-22120-4","volume":"12","author":"ME March","year":"2021","unstructured":"March ME, Gutierrez-Uzquiza A, Snorradottir AO, Matsuoka LS, Balvis NF, Gestsson T, et al. NAC blocks Cystatin C amyloid complex aggregation in a cell system and in skin of HCCAA patients. Nat Commun 2021, 12: 1827.","journal-title":"Nat Commun"},{"key":"1730_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161093","volume":"11","author":"XF Wang","year":"2016","unstructured":"Wang XF, Liu DX, Liang Y, Xing LL, Zhao WH, Qin XX, et al. Cystatin C shifts APP processing from amyloid-\u03b2 production towards non-amyloidgenic pathway in brain endothelial cells. PLoS One 2016, 11: e0161093.","journal-title":"PLoS One"},{"key":"1730_CR150","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209267","volume":"102","author":"AK Kancheva","year":"2024","unstructured":"Kancheva AK, Wardlaw JM, Lyall DM, Quinn TJ. Clinical phenotypes associated with cerebral small vessel disease: An overview of systematic reviews. Neurology 2024, 102: e209267.","journal-title":"Neurology"},{"key":"1730_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105750","volume":"170","author":"Q Yang","year":"2022","unstructured":"Yang Q, Wei X, Deng B, Chang Z, Jin D, Huang Y, et al. Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment. Neurobiol Dis 2022, 170: 105750.","journal-title":"Neurobiol Dis"},{"key":"1730_CR152","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1152\/physrev.00028.2024","volume":"105","author":"HS Markus","year":"2025","unstructured":"Markus HS, Joutel A. The pathogenesis of cerebral small vessel disease and vascular cognitive impairment. Physiol Rev 2025, 105: 1075\u20131171.","journal-title":"Physiol Rev"},{"key":"1730_CR153","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209136","volume":"102","author":"H Van Den Brink","year":"2024","unstructured":"Van Den Brink H, Pham S, Siero JC, Arts T, Onkenhout L, Kuijf H, et al. Assessment of small vessel function using 7T MRI in patients with sporadic cerebral small vessel disease: The ZOOM@SVDs study. Neurology 2024, 102: e209136.","journal-title":"Neurology"},{"key":"1730_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101885","volume":"86","author":"J Xu","year":"2023","unstructured":"Xu J, Su Y, Fu J, Shen Y, Dong Q, Cheng X. Glymphatic pathway in sporadic cerebral small vessel diseases: From bench to bedside. Ageing Res Rev 2023, 86: 101885.","journal-title":"Ageing Res Rev"},{"key":"1730_CR155","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1177\/23969873231196981","volume":"8","author":"S Yang","year":"2023","unstructured":"Yang S, Webb AJS. Associations between neurovascular coupling and cerebral small vessel disease: A systematic review and meta-analysis. Eur Stroke J 2023, 8: 895\u2013903.","journal-title":"Eur Stroke J"},{"key":"1730_CR156","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.tins.2022.08.004","volume":"45","author":"PJ Drew","year":"2022","unstructured":"Drew PJ. Neurovascular coupling: Motive unknown. Trends Neurosci 2022, 45: 809\u2013819.","journal-title":"Trends Neurosci"},{"key":"1730_CR157","doi-asserted-by":"crossref","unstructured":"Winovich DT, Longstreth WT Jr, Arnold AM, Varadhan R, Zeki Al Hazzouri A, Cushman M, et al. Factors associated with ischemic stroke survival and recovery in older adults. Stroke 2017, 48: 1818\u20131826.","DOI":"10.1161\/STROKEAHA.117.016726"},{"key":"1730_CR158","doi-asserted-by":"publisher","first-page":"1355948","DOI":"10.3389\/fendo.2024.1355948","volume":"15","author":"Y Qi","year":"2024","unstructured":"Qi Y, Shang X, Han T, Han N, Jiang Z, Yan H, et al. Serum cystatin C and stroke risk: A national cohort and Mendelian randomization study. Front Endocrinol 2024, 15: 1355948.","journal-title":"Front Endocrinol"},{"key":"1730_CR159","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00415-012-6453-2","volume":"259","author":"D Xiao","year":"2012","unstructured":"Xiao D, Liu H, Zhang H, Luo Y. Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke. J Neurol 2012, 259: 2053\u20132059.","journal-title":"J Neurol"},{"key":"1730_CR160","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s10143-022-01765-9","volume":"45","author":"K Chen","year":"2022","unstructured":"Chen K, Huang G, Cai C, Yan C, Zhang F, Yao M, et al. Higher cystatin C level increases the risk of delayed cerebral ischemia after endovascular treatment of aneurysmal subarachnoid hemorrhage: A case-control study. Neurosurg Rev 2022, 45: 2407\u20132415.","journal-title":"Neurosurg Rev"},{"key":"1730_CR161","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/clc.23959","volume":"46","author":"F Luo","year":"2023","unstructured":"Luo F, Luo JY, Liu F, Qiu YJ, Tian XX, Zeng L, et al. Coronary artery calcium and cystatin C for risk stratification of MACCEs and all-cause death in symptomatic patients. Clin Cardiol 2023, 46: 195\u2013203.","journal-title":"Clin Cardiol"},{"key":"1730_CR162","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/ene.14663","volume":"28","author":"Z Chang","year":"2021","unstructured":"Chang Z, Zou H, Xie Z, Deng B, Que R, Huang Z, et al. Cystatin C is a potential predictor of unfavorable outcomes for cerebral ischemia with intravenous tissue plasminogen activator treatment: A multicenter prospective nested case\u2013control study. Eur J Neurol 2021, 28: 1265\u20131274.","journal-title":"Eur J Neurol"},{"key":"1730_CR163","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1161\/STROKEAHA.107.489625","volume":"38","author":"L Ni","year":"2007","unstructured":"Ni L, L\u00fc J, Hou LB, Yan JT, Fan Q, Hui R, et al. Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke 2007, 38: 3287\u20133288.","journal-title":"Stroke"},{"key":"1730_CR164","doi-asserted-by":"publisher","first-page":"1049738","DOI":"10.3389\/fpubh.2023.1049738","volume":"11","author":"L Hou","year":"2023","unstructured":"Hou L, Chen X, Zhu C. A baseline sarcopenia index based on creatinine\/cystatin C for the prediction of stroke recurrence and mortality in older survivors of first ischemic strokes. Front Public Health 2023, 11: 1049738.","journal-title":"Front Public Health"},{"key":"1730_CR165","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2147\/NDT.S412825","volume":"19","author":"L Zuo","year":"2023","unstructured":"Zuo L, Dong Y, Pan Y, Yan H, Meng X, Li H, et al. Impact of serum cystatin C level on long-term cognitive impairment after acute ischemic stroke and transient ischemic attack. Neuropsychiatr Dis Treat 2023, 19: 1543\u20131554.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1730_CR166","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1161\/STROKEAHA.122.039277","volume":"53","author":"D Yao","year":"2022","unstructured":"Yao D, Li S, Jing J, Cai X, Jin A, Yang Y, et al. Association of serum cystatin C with cerebral small vessel disease in community-based population. Stroke 2022, 53: 3123\u20133132.","journal-title":"Stroke"},{"key":"1730_CR167","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ijs.12465","volume":"10","author":"S Akoudad","year":"2015","unstructured":"Akoudad S, Sedaghat S, Hofman A, Koudstaal PJ, van der Lugt A, Ikram MA, et al. Kidney function and cerebral small vessel disease in the general population. Int J Stroke 2015, 10: 603\u2013608.","journal-title":"Int J Stroke"},{"key":"1730_CR168","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.007","volume":"26","author":"S Yang","year":"2017","unstructured":"Yang S, Cai J, Lu R, Wu J, Zhang M, Zhou X. Association between serum cystatin C level and total magnetic resonance imaging burden of cerebral small vessel disease in patients with acute lacunar stroke. J Stroke Cerebrovasc Dis 2017, 26: 186\u2013191.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1730_CR169","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000527069","volume":"52","author":"CY Xiao","year":"2023","unstructured":"Xiao CY, Ma YH, Ou YN, Zhao B, Hu HY, Wang ZT, et al. Association between kidney function and the burden of cerebral small vessel disease: An updated meta-analysis and systematic review. Cerebrovasc Dis 2023, 52: 376\u2013386.","journal-title":"Cerebrovasc Dis"},{"key":"1730_CR170","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1471-2377-14-127","volume":"14","author":"MY Oh","year":"2014","unstructured":"Oh MY, Lee H, Kim JS, Ryu WS, Lee SH, Ko SB, et al. Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds. BMC Neurol 2014, 14: 127.","journal-title":"BMC Neurol"},{"key":"1730_CR171","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jocn.2013.04.014","volume":"21","author":"JB Zhang","year":"2014","unstructured":"Zhang JB, J\u00fc XH, Wang J, Sun HR, Li F. Serum cystatin C and cerebral microbleeds in patients with acute cerebral stroke. J Clin Neurosci 2014, 21: 268\u2013273.","journal-title":"J Clin Neurosci"},{"key":"1730_CR172","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1468-1331.2009.02809.x","volume":"17","author":"M Wada","year":"2010","unstructured":"Wada M, Nagasawa H, Kawanami T, Kurita K, Daimon M, Kubota I, et al. Cystatin C as an index of cerebral small vessel disease: Results of a cross-sectional study in community-based Japanese elderly. Eur J Neurol 2010, 17: 383\u2013390.","journal-title":"Eur J Neurol"},{"key":"1730_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.bandc.2023.105999","volume":"169","author":"R Yang","year":"2023","unstructured":"Yang R, Li J, Qin Y, Zhao L, Liu R, Yang F, et al. A bibliometric analysis of cerebral microbleeds and cognitive impairment. Brain Cogn 2023, 169: 105999.","journal-title":"Brain Cogn"},{"key":"1730_CR174","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/j.ajkd.2022.07.013","volume":"81","author":"JB Scheppach","year":"2023","unstructured":"Scheppach JB, Wu A, Gottesman RF, Mosley TH, Arsiwala-Scheppach LT, Knopman DS, et al. Association of kidney function measures with signs of neurodegeneration and small vessel disease on brain magnetic resonance imaging: The atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 2023, 81: 261\u2013269.e1.","journal-title":"Am J Kidney Dis"},{"key":"1730_CR175","first-page":"111","volume":"46","author":"C Lin","year":"2003","unstructured":"Lin C, Wang ST, Wu CW, Chuo LJ, Kuo YM. The association of a cystatin C gene polymorphism with late-onset Alzheimer\u2019s disease and vascular dementia. Chin J Physiol 2003, 46: 111\u2013115.","journal-title":"Chin J Physiol"},{"key":"1730_CR176","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214481","volume":"106","author":"S Prapiadou","year":"2026","unstructured":"Prapiadou S, Tan BYQ, Kimball TN, Mora S, Tack RWP, Choksi D, et al. Association of plasma GFAP and NfL in middle-aged adults with MRI markers of cerebral small vessel disease later in life. Neurology 2026, 106: e214481.","journal-title":"Neurology"},{"key":"1730_CR177","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214220","volume":"105","author":"NC Edwards","year":"2025","unstructured":"Edwards NC, Lao P, Alshikho MJ, Mazen J, Huber B, Hale C, et al. Alzheimer disease, vascular disease, and blood-brain barrier permeability biomarkers in middle-aged adults. Neurology 2025, 105: e214220.","journal-title":"Neurology"},{"key":"1730_CR178","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2026.11335","volume":"9","author":"R Shikimoto","year":"2026","unstructured":"Shikimoto R, Sasaki T, Abe Y, Tai K, Hirose N, Okano H, et al. Biomarkers, cognitive function, and mortality in centenarians. JAMA Netw Open 2026, 9: e2611335.","journal-title":"JAMA Netw Open"},{"key":"1730_CR179","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71422","volume":"22","author":"S Shrestha","year":"2026","unstructured":"Shrestha S, Zhu X, Windham BG, Sullivan KJ, Palta P, Gottesman RF, et al. Associations of blood biomarkers of glial cell dysfunction and neuronal injury with future cognitive decline and incident dementia. Alzheimers Dement 2026, 22: e71422.","journal-title":"Alzheimers Dement"},{"key":"1730_CR180","doi-asserted-by":"publisher","DOI":"10.1002\/cns.70780","volume":"32","author":"T Lan","year":"2026","unstructured":"Lan T, Wang C, Yan Y, Yang T, Cui J, Lei R, et al. Plasma GFAP and NLRP3 associate with cognitive impairment after recent small subcortical infarct via periventricular white matter hyperintensity. CNS Neurosci Ther 2026, 32: e70780.","journal-title":"CNS Neurosci Ther"},{"key":"1730_CR181","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.766516","volume":"12","author":"C Xin","year":"2021","unstructured":"Xin C, Xie J, Fan H, Sun X, Shi B. Association between serum cystatin C and thyroid diseases: A systematic review and meta-analysis. Front Endocrinol 2021, 12: 766516.","journal-title":"Front Endocrinol"},{"key":"1730_CR182","unstructured":"Russel WA, Engberink RO, Creon A, Caldinelli A, Faucon AL, Grams ME, et al. Medications influencing serum cystatin C independent of measured GFR. J Am Soc Nephrol 2026, pii: 00001751-990000000-00994."},{"key":"1730_CR183","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s10157-010-0334-8","volume":"14","author":"T Okura","year":"2010","unstructured":"Okura T, Jotoku M, Irita J, Enomoto D, Nagao T, Desilva VR, et al. Association between cystatin C and inflammation in patients with essential hypertension. Clin Exp Nephrol 2010, 14: 584\u2013588.","journal-title":"Clin Exp Nephrol"},{"key":"1730_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.711155","volume":"12","author":"H Jiao","year":"2021","unstructured":"Jiao H, Zhang M, Zhang Y, Wang Y, Li WD. Pathway association studies reveal gene loci and pathway networks that associated with plasma cystatin C levels. Front Genet 2021, 12: 711155.","journal-title":"Front Genet"},{"key":"1730_CR185","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41573-024-01105-0","volume":"24","author":"O Antico","year":"2025","unstructured":"Antico O, Thompson PW, Hertz NT, Muqit MMK, Parton LE. Targeting mitophagy in neurodegenerative diseases. Nat Rev Drug Discov 2025, 24: 276\u2013299.","journal-title":"Nat Rev Drug Discov"},{"key":"1730_CR186","doi-asserted-by":"publisher","unstructured":"Behl T, Jayabalan K, Ballal S, Sahoo S, Jayasingh Chellammal HS, Gulati M, et al. A age related vascular senescence: Mystery of blood-brain barrier dysfunction in neurodegeneration. Mol Neurobiol 2026, 63. https:\/\/doi.org\/10.1007\/s12035-026-05984-9.","DOI":"10.1007\/s12035-026-05984-9"},{"key":"1730_CR187","doi-asserted-by":"crossref","unstructured":"Patel S, Prajapati C, Rai SN, Singh SK. Bridging pathway dysfunction and therapy: Novel compounds for neuroprotection. 3 Biotech 2026, 16: 79.","DOI":"10.1007\/s13205-026-04697-z"},{"key":"1730_CR188","doi-asserted-by":"crossref","unstructured":"Mohanty R, Wheatley S, Chiotis K, Marseglia A, Westman E, for the Alzheimer\u2019s Disease Neuroimaging Initiative Cohort. Distinct cerebrovascular pathways underlying Alzheimer\u2019s disease-related neurodegeneration. Acta Neuropathol 2025, 150: 64.","DOI":"10.1007\/s00401-025-02970-8"},{"key":"1730_CR189","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC. Alzheimer\u2019s disease: From immunotherapy to immunoprevention. Cell 2023, 186: 4260\u20134270.","journal-title":"Cell"},{"key":"1730_CR190","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson\u2019s disease. Lancet 2024, 403: 293\u2013304.","journal-title":"Lancet"},{"key":"1730_CR191","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/brain\/awag159","volume":"149","author":"F Di Pede","year":"2026","unstructured":"Di Pede F, Cabras S, Manera U, Vasta R, Zocco G, Minerva E, et al. King\u2019s stages of amyotrophic lateral sclerosis: An 18F-FDG-PET study of brain connectivity. Brain 2026, 149: 2495\u20132504.","journal-title":"Brain"},{"key":"1730_CR192","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X. Alzheimer\u2019s disease: Insights into pathology, molecular mechanisms, and therapy. Protein Cell 2025, 16: 83\u2013120.","journal-title":"Protein Cell"},{"key":"1730_CR193","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1124\/jpet.108.147082","volume":"328","author":"DM Klein","year":"2009","unstructured":"Klein DM, Felsenstein KM, Brenneman DE. Cathepsins B and L differentially regulate amyloid precursor protein processing. J Pharmacol Exp Ther 2009, 328: 813\u2013821.","journal-title":"J Pharmacol Exp Ther"},{"key":"1730_CR194","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1515\/BC.2005.151","volume":"386","author":"V Hook","year":"2005","unstructured":"Hook V, Toneff T, Bogyo M, Greenbaum D, Medzihradszky KF, Neveu J, et al. Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: Evidence for cathepsin B as a candidate beta-secretase of Alzheimer\u2019s disease. Biol Chem 2005, 386: 931\u2013940.","journal-title":"Biol Chem"},{"key":"1730_CR195","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JAD-131370","volume":"41","author":"G Hook","year":"2014","unstructured":"Hook G, Yu J, Toneff T, Kindy M, Hook V. Brain pyroglutamate amyloid-\u03b2 is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer\u2019s disease therapeutic. J Alzheimers Dis 2014, 41: 129\u2013149.","journal-title":"J Alzheimers Dis"},{"key":"1730_CR196","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bbi.2017.06.002","volume":"65","author":"Z Wu","year":"2017","unstructured":"Wu Z, Ni J, Liu Y, Teeling JL, Takayama F, Collcutt A, et al. Cathepsin B plays a critical role in inducing Alzheimer\u2019s disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice. Brain Behav Immun 2017, 65: 350\u2013361.","journal-title":"Brain Behav Immun"},{"key":"1730_CR197","doi-asserted-by":"crossref","unstructured":"Viana GM, Gonzalez EA, Alvarez MMP, Cavalheiro RP, do Nascimento CC, Baldo G, et al. Cathepsin B-associated activation of amyloidogenic pathway in murine mucopolysaccharidosis type I brain cortex. Int J Mol Sci 2020, 21: 1459.","DOI":"10.3390\/ijms21041459"},{"key":"1730_CR198","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.1074\/jbc.M708362200","volume":"283","author":"VYH Hook","year":"2008","unstructured":"Hook VYH, Kindy M, Hook G. Inhibitors of cathepsin B improve memory and reduce \u03b2-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, \u03b2-secretase site of the amyloid precursor protein. J Biol Chem 2008, 283: 7745\u20137753.","journal-title":"J Biol Chem"},{"key":"1730_CR199","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3390\/cells14151179","volume":"14","author":"MK Singh","year":"2025","unstructured":"Singh MK, Fu M, Han S, Ranbhise JS, Choe W, Kim SS, et al. Chaperone-mediated responses and mitochondrial\u2013endoplasmic reticulum coupling: Emerging insight into Alzheimer\u2019s disease. Cells 2025, 14: 1179.","journal-title":"Cells"},{"key":"1730_CR200","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/s41593-025-01971-w","volume":"28","author":"JF da Rocha","year":"2025","unstructured":"da Rocha JF, Lance ML, Luo R, Schlachter P, Moreira L, Iqbal MA, et al. Protective exercise responses in the dentate gyrus of Alzheimer\u2019s disease mouse model revealed with single-nucleus RNA-sequencing. Nat Neurosci 2025, 28: 1546\u20131561.","journal-title":"Nat Neurosci"},{"key":"1730_CR201","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1124\/pharmrev.121.000527","volume":"74","author":"G Hook","year":"2022","unstructured":"Hook G, Reinheckel T, Ni J, Wu Z, Kindy M, Peters C, et al. Cathepsin B gene knockout improves behavioral deficits and reduces pathology in models of neurologic disorders. Pharmacol Rev 2022, 74: 600\u2013629.","journal-title":"Pharmacol Rev"},{"key":"1730_CR202","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2174\/1389557522666220214095859","volume":"22","author":"A Sharma","year":"2022","unstructured":"Sharma A, Swetha R, Bajad NG, Ganeshpurkar A, Singh R, Kumar A, et al. Cathepsin B-a neuronal death mediator in Alzheimer\u2019s disease leading to neurodegeneration. Mini Rev Med Chem 2022, 22: 2012\u20132023.","journal-title":"Mini Rev Med Chem"},{"key":"1730_CR203","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuron.2008.10.001","volume":"60","author":"B Sun","year":"2008","unstructured":"Sun B, Zhou Y, Halabisky B, Lo I, Cho SH, Mueller-Steiner S, et al. Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer\u2019s disease. Neuron 2008, 60: 247\u2013257.","journal-title":"Neuron"},{"key":"1730_CR204","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","volume":"51","author":"S Mueller-Steiner","year":"2006","unstructured":"Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, et al. Antiamyloidogenic and neuroprotective functions of cathepsin B: Implications for Alzheimer\u2019s disease. Neuron 2006, 51: 703\u2013714.","journal-title":"Neuron"},{"key":"1730_CR205","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","volume":"182","author":"WT Chen","year":"2020","unstructured":"Chen WT, Lu A, Craessaerts K, Pavie B, Sala Frigerio C, Corthout N, et al. Spatial transcriptomics and in situ sequencing to study Alzheimer\u2019s disease. Cell 2020, 182: 976\u2013991.e19.","journal-title":"Cell"},{"key":"1730_CR206","doi-asserted-by":"crossref","unstructured":"Burke AD, Goldfarb D. Diagnosing and treating Alzheimer disease during the early stage. J Clin Psychiatry 2023, 84: LI21019AH3C.","DOI":"10.4088\/JCP.LI21019AH3C"},{"key":"1730_CR207","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00401-024-02799-7","volume":"148","author":"RA Nixon","year":"2024","unstructured":"Nixon RA. Autophagy-lysosomal-associated neuronal death in neurodegenerative disease. Acta Neuropathol 2024, 148: 42.","journal-title":"Acta Neuropathol"},{"key":"1730_CR208","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1093\/brain\/awaf222","volume":"148","author":"S Jiang","year":"2025","unstructured":"Jiang S, Srikanth M, Serpe R, Yavari S, Gaur P, Collins GA, et al. Early proteasome downregulation and dysfunction drive proteostasis failure in Alzheimer\u2019s disease. Brain 2025, 148: 4372\u20134388.","journal-title":"Brain"},{"key":"1730_CR209","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/jnen\/60.1.94","volume":"60","author":"E Levy","year":"2001","unstructured":"Levy E, Sastre M, Kumar A, Gallo G, Piccardo P, Ghetti B, et al. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol 2001, 60: 94\u2013104.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1730_CR210","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JAD-2009-1147","volume":"18","author":"W Mi","year":"2009","unstructured":"Mi W, Jung SS, Yu H, Schmidt SD, Nixon RA, Mathews PM, et al. Complexes of amyloid-beta and cystatin C in the human central nervous system. J Alzheimers Dis 2009, 18: 273\u2013280.","journal-title":"J Alzheimers Dis"},{"key":"1730_CR211","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/ng.2007.23","volume":"39","author":"SA Kaeser","year":"2007","unstructured":"Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, et al. Cystatin C modulates cerebral beta-amyloidosis. Nat Genet 2007, 39: 1437\u20131439.","journal-title":"Nat Genet"},{"key":"1730_CR212","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.neurobiolaging.2003.11.006","volume":"25","author":"M Sastre","year":"2004","unstructured":"Sastre M, Calero M, Pawlik M, Mathews PM, Kumar A, Danilov V, et al. Binding of cystatin C to Alzheimer\u2019s amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol Aging 2004, 25: 1033\u20131043.","journal-title":"Neurobiol Aging"},{"key":"1730_CR213","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/00365510601009738","volume":"67","author":"ML Selenica","year":"2007","unstructured":"Selenica ML, Wang X, Ostergaard-Pedersen L, Westlind-Danielsson A, Grubb A. Cystatin C reduces the in vitro formation of soluble Abeta1-42 oligomers and protofibrils. Scand J Clin Lab Invest 2007, 67: 179\u2013190.","journal-title":"Scand J Clin Lab Invest"},{"key":"1730_CR214","doi-asserted-by":"publisher","first-page":"20833","DOI":"10.1038\/s41598-023-47514-w","volume":"13","author":"A \u017by\u0142a","year":"2023","unstructured":"\u017by\u0142a A, Martel A, Jurczak P, Moli\u0144ski A, Szyma\u0144ska A, Kozak M. Human cystatin C induces the disaggregation process of selected amyloid beta peptides: A structural and kinetic view. Sci Rep 2023, 13: 20833.","journal-title":"Sci Rep"},{"key":"1730_CR215","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/ijbs.57078","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H, et al. Interaction between a\u03b2 and tau in the pathogenesis of Alzheimer\u2019s disease. Int J Biol Sci 2021, 17: 2181\u20132192.","journal-title":"Int J Biol Sci"},{"key":"1730_CR216","doi-asserted-by":"publisher","first-page":"1490275","DOI":"10.3389\/fmolb.2024.1490275","volume":"11","author":"ASF Man\u00e7ano","year":"2024","unstructured":"Man\u00e7ano ASF, Pina JG, Froes BR, Sciani JM. Autophagy-lysosomal pathway impairment and cathepsin dysregulation in Alzheimer\u2019s disease. Front Mol Biosci 2024, 11: 1490275.","journal-title":"Front Mol Biosci"},{"key":"1730_CR217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055328","volume":"8","author":"XM Zhong","year":"2013","unstructured":"Zhong XM, Hou L, Luo XN, Shi HS, Hu GY, He HB, et al. Alterations of CSF cystatin C levels and their correlations with CSF \u0391\u03b240 and \u0391\u03b242 levels in patients with Alzheimer\u2019s disease, dementia with lewy bodies and the atrophic form of general paresis. PLoS One 2013, 8: e55328.","journal-title":"PLoS One"},{"key":"1730_CR218","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0002-9440(10)61781-6","volume":"159","author":"A Deng","year":"2001","unstructured":"Deng A, Irizarry MC, Nitsch RM, Growdon JH, Rebeck GW. Elevation of cystatin C in susceptible neurons in Alzheimer\u2019s disease. Am J Pathol 2001, 159: 1061\u20131068.","journal-title":"Am J Pathol"},{"key":"1730_CR219","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/jnc.15002","volume":"154","author":"O Corti","year":"2020","unstructured":"Corti O, Blomgren K, Poletti A, Beart PM. Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases. J Neurochem 2020, 154: 354\u2013371.","journal-title":"J Neurochem"},{"key":"1730_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-021-00736-9","volume":"12","author":"KC Chang","year":"2022","unstructured":"Chang KC, Liu PF, Chang CH, Lin YC, Chen YJ, Shu CW. The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases. Cell Biosci 2022, 12: 1.","journal-title":"Cell Biosci"},{"key":"1730_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.100972","volume":"82","author":"BN Lizama","year":"2021","unstructured":"Lizama BN, Chu CT. Neuronal autophagy and mitophagy in Parkinson\u2019s disease. Mol Aspects Med 2021, 82: 100972.","journal-title":"Mol Aspects Med"},{"key":"1730_CR222","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jcpe.14109","volume":"52","author":"M Jiang","year":"2025","unstructured":"Jiang M, Ge Z, Yin S, Liu Y, Gao H, Lu L, et al. Cathepsin B modulates Alzheimer\u2019s disease pathology through SAPK\/JNK signals following administration of Porphyromonas gingivalis-derived outer membrane vesicles. J Clin Periodontol 2025, 52: 434\u2013456.","journal-title":"J Clin Periodontol"},{"key":"1730_CR223","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14393","volume":"24","author":"PP Liu","year":"2025","unstructured":"Liu PP, Liu XH, Ren MJ, Liu XT, Shi XQ, Li ML, et al. Neuronal cathepsin S increases neuroinflammation and causes cognitive decline via CX3CL1-CX3CR1 axis and JAK2-STAT3 pathway in aging and Alzheimer\u2019s disease. Aging Cell 2025, 24: e14393.","journal-title":"Aging Cell"},{"key":"1730_CR224","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.2353\/ajpath.2010.100461","volume":"177","author":"G Kaur","year":"2010","unstructured":"Kaur G, Mohan P, Pawlik M, DeRosa S, Fajiculay J, Che S, et al. Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy. Am J Pathol 2010, 177: 2256\u20132267.","journal-title":"Am J Pathol"},{"key":"1730_CR225","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3233\/JAD-2010-1291","volume":"19","author":"B Tizon","year":"2010","unstructured":"Tizon B, Ribe EM, Mi W, Troy CM, Levy E. Cystatin C protects neuronal cells from amyloid-beta-induced toxicity. J Alzheimers Dis 2010, 19: 885\u2013894.","journal-title":"J Alzheimers Dis"},{"key":"1730_CR226","doi-asserted-by":"publisher","first-page":"428","DOI":"10.7150\/thno.103455","volume":"15","author":"M Park","year":"2025","unstructured":"Park M, Ryu H, Heo S, Kim B, Park J, Lim KH, et al. Targeted demethylation of cathepsin D via epigenome editing rescues pathology in Alzheimer\u2019s disease mouse model. Theranostics 2025, 15: 428\u2013438.","journal-title":"Theranostics"},{"key":"1730_CR227","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/15548627.2022.2045534","volume":"18","author":"S Prieto Huarcaya","year":"2022","unstructured":"Prieto Huarcaya S, Drobny A, Marques ARA, Di Spiezio A, Dobert JP, Balta D, et al. Recombinant pro-CTSD (cathepsin D) enhances SNCA\/\u03b1-Synuclein degradation in \u03b1-Synucleinopathy models. Autophagy 2022, 18: 1127\u20131151.","journal-title":"Autophagy"},{"key":"1730_CR228","doi-asserted-by":"publisher","first-page":"2300202","DOI":"10.1002\/pmic.202300202","volume":"24","author":"C Contini","year":"2024","unstructured":"Contini C, Fadda L, Lai G, Masala C, Olianas A, Castagnola M, et al. A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson\u2019s disease with respect to Alzheimer\u2019s disease patients and to healthy controls. PROTEOMICS 2024, 24: 2300202.","journal-title":"PROTEOMICS"},{"key":"1730_CR229","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JAD-2009-0966","volume":"16","author":"SF Hansson","year":"2009","unstructured":"Hansson SF, Andr\u00e9asson U, Wall M, Skoog I, Andreasen N, Wallin A, et al. Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer\u2019s disease patients. J Alzheimers Dis 2009, 16: 389\u2013397.","journal-title":"J Alzheimers Dis"},{"key":"1730_CR230","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1159\/000110576","volume":"24","author":"AH Simonsen","year":"2007","unstructured":"Simonsen AH, McGuire J, Podust VN, Hagnelius NO, Nilsson TK, Kapaki E, et al. A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer\u2019s disease versus normal aging and frontotemporal dementia. Dement Geriatr Cogn Disord 2007, 24: 434\u2013440.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1730_CR231","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/824024","volume":"2012","author":"AH Simonsen","year":"2012","unstructured":"Simonsen AH, Hagnelius NO, Waldemar G, Nilsson TK, McGuire J. Protein markers for the differential diagnosis of vascular dementia and Alzheimer\u2019s disease. Int J Proteomics 2012, 2012: 824024.","journal-title":"Int J Proteomics"},{"key":"1730_CR232","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.58","volume":"4","author":"RW Paterson","year":"2014","unstructured":"Paterson RW, Bartlett JW, Blennow K, Fox NC, Shaw LM, Trojanowski JQ, et al. Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals. Transl Psychiatry 2014, 4: e419.","journal-title":"Transl Psychiatry"},{"key":"1730_CR233","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3233\/JAD-2010-091594","volume":"21","author":"J Sundel\u00f6f","year":"2010","unstructured":"Sundel\u00f6f J, Sundstr\u00f6m J, Hansson O, Eriksdotter-J\u00f6nhagen M, Giedraitis V, Larsson A, et al. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer\u2019s disease, mild cognitive impairment, and healthy controls. J Alzheimers Dis 2010, 21: 471\u2013478.","journal-title":"J Alzheimers Dis"},{"key":"1730_CR234","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-015-0059-y","volume":"10","author":"WE Heywood","year":"2015","unstructured":"Heywood WE, Galimberti D, Bliss E, Sirka E, Paterson RW, Magdalinou NK, et al. Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Mol Neurodegener 2015, 10: 64.","journal-title":"Mol Neurodegener"},{"key":"1730_CR235","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1212\/01.wnl.0000326894.40353.93","volume":"71","author":"J Sundel\u00f6f","year":"2008","unstructured":"Sundel\u00f6f J, Arnl\u00f6v J, Ingelsson E, Sundstr\u00f6m J, Basu S, Zethelius B, et al. Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology 2008, 71: 1072\u20131079.","journal-title":"Neurology"},{"key":"1730_CR236","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3233\/JAD-2010-101095","volume":"22","author":"R Ghidoni","year":"2010","unstructured":"Ghidoni R, Benussi L, Glionna M, Desenzani S, Albertini V, Levy E, et al. Plasma cystatin C and risk of developing Alzheimer\u2019s disease in subjects with mild cognitive impairment. J Alzheimers Dis 2010, 22: 985\u2013991.","journal-title":"J Alzheimers Dis"},{"key":"1730_CR237","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/ana.21383","volume":"63","author":"K Yaffe","year":"2008","unstructured":"Yaffe K, Lindquist K, Shlipak MG, Simonsick E, Fried L, Rosano C, et al. Cystatin C as a marker of cognitive function in Elders: Findings from the health ABC study. Ann Neurol 2008, 63: 798\u2013802.","journal-title":"Ann Neurol"},{"key":"1730_CR238","doi-asserted-by":"publisher","first-page":"153331752096510","DOI":"10.1177\/1533317520965101","volume":"35","author":"Z Cui","year":"2020","unstructured":"Cui Z, Cao G, Wang Y, Ma Q, Wang C, Xu Y, et al. Effects of cystatin C on cognitive impairment in older Chinese adults. Am J Alzheimers Dis Other Demen 2020, 35: 1533317520965101.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"1730_CR239","doi-asserted-by":"publisher","first-page":"1052435","DOI":"10.3389\/fnhum.2023.1052435","volume":"17","author":"C Higgins Tejera","year":"2023","unstructured":"Higgins Tejera C, Ware EB, Kobayashi LC, Fu M, Hicken M, Zawistowski M, et al. Decomposing interaction and mediating effects of race\/ethnicity and circulating blood levels of cystatin C on cognitive status in the United States health and retirement study. Front Hum Neurosci 2023, 17: 1052435.","journal-title":"Front Hum Neurosci"},{"key":"1730_CR240","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.790939","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Huang Y, Bao T, Jia F, Ou R, Wei Q, et al. Changes in serum cystatin C levels and the associations with cognitive function in Alzheimer\u2019s disease patients. Front Aging Neurosci 2022, 13: 790939.","journal-title":"Front Aging Neurosci"},{"key":"1730_CR241","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/gerona\/glu189","volume":"70","author":"Y Slinin","year":"2015","unstructured":"Slinin Y, Peters KW, Ishani A, Yaffe K, Fink HA, Stone KL, et al. Cystatin C and cognitive impairment 10 years later in older women. J Gerontol Ser A Biol Sci Med Sci 2015, 70: 771\u2013778.","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"1730_CR242","doi-asserted-by":"publisher","unstructured":"Schindler SE, Petersen KK, Saef B, Tosun D, Shaw LM, Zetterberg H, et al. Head-to-head comparison of leading blood tests for Alzheimer\u2019s disease pathology. medRxiv 2024. https:\/\/doi.org\/10.1101\/2024.06.12.24308839.","DOI":"10.1101\/2024.06.12.24308839"},{"key":"1730_CR243","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-025-00819-y","volume":"20","author":"DR Thal","year":"2025","unstructured":"Thal DR, Poesen K, Vandenberghe R, De Meyer S. Alzheimer\u2019s disease neuropathology and its estimation with fluid and imaging biomarkers. Mol Neurodegener 2025, 20: 33.","journal-title":"Mol Neurodegener"},{"key":"1730_CR244","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70038","volume":"21","author":"J Wang","year":"2025","unstructured":"Wang J, Huang S, Lan G, Lai YJ, Wang QH, Chen Y, et al. Diagnostic accuracy of plasma p-tau217\/A\u03b242 for Alzheimer\u2019s disease in clinical and community cohorts. Alzheimers Dement 2025, 21: e70038.","journal-title":"Alzheimers Dement"},{"key":"1730_CR245","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/WNN.0000000000000100","volume":"29","author":"WD Hu","year":"2016","unstructured":"Hu WD, Chen J, Mao CJ, Feng P, Yang YP, Luo WF, et al. Elevated cystatin C levels are associated with cognitive impairment and progression of Parkinson disease. Cogn Behav Neurol 2016, 29: 144\u2013149.","journal-title":"Cogn Behav Neurol"},{"key":"1730_CR246","doi-asserted-by":"publisher","first-page":"349","DOI":"10.31083\/j.jin2002034","volume":"20","author":"CG Yang","year":"2021","unstructured":"Yang CG, Cai SM, Liu CY, Chen C. On the correlation between serum Cystatin C and Parkinson\u2019s disease in the Chinese population: A promising biomarker? J Integr Neurosci 2021, 20: 349\u2013357.","journal-title":"J Integr Neurosci"},{"key":"1730_CR247","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/psyg.12483","volume":"20","author":"J Li","year":"2020","unstructured":"Li J, Gu C, Zhu M, Li D, Chen L, Zhu X. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson\u2019s disease. Psychogeriatrics 2020, 20: 180\u2013188.","journal-title":"Psychogeriatrics"},{"key":"1730_CR248","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neulet.2019.05.002","volume":"705","author":"X Dong","year":"2019","unstructured":"Dong X, Zheng D, Nao J. Measurement of serum cystatin C: A valuable tool for evaluating dyskinesia in Parkinson\u2019s disease. Neurosci Lett 2019, 705: 172\u2013176.","journal-title":"Neurosci Lett"},{"key":"1730_CR249","doi-asserted-by":"publisher","first-page":"907","DOI":"10.4103\/0366-6999.229902","volume":"131","author":"KP Xiong","year":"2018","unstructured":"Xiong KP, Dai YP, Chen J, Xu JM, Wang Y, Feng P, et al. Increased serum cystatin C in early Parkinson\u2019s disease with objective sleep disturbances. Chin Med J 2018, 131: 907\u2013911.","journal-title":"Chin Med J"},{"key":"1730_CR250","first-page":"2957","volume":"19","author":"WW Chen","year":"2015","unstructured":"Chen WW, Cheng X, Zhang X, Zhang QS, Sun HQ, Huang WJ, et al. The expression features of serum Cystatin C and homocysteine of Parkinson\u2019s disease with mild cognitive dysfunction. Eur Rev Med Pharmacol Sci 2015, 19: 2957\u20132963.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1730_CR251","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000523982","volume":"21","author":"A Imarisio","year":"2021","unstructured":"Imarisio A, Pilotto A, Garrafa E, Conforti F, Masciocchi S, Turrone R, et al. Plasma cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson\u2019s disease. Neurodegener Dis 2021, 21: 109\u2013116.","journal-title":"Neurodegener Dis"},{"key":"1730_CR252","doi-asserted-by":"publisher","first-page":"1069837","DOI":"10.3389\/fnagi.2022.1069837","volume":"14","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li R, Hou Y, Cao B, Wei Q, Ou R, et al. Cystatin C predicts cognitive decline in multiple system atrophy: A 1-year prospective cohort study. Front Aging Neurosci 2022, 14: 1069837.","journal-title":"Front Aging Neurosci"},{"key":"1730_CR253","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2009.01.026","volume":"452","author":"S Tsuji-Akimoto","year":"2009","unstructured":"Tsuji-Akimoto S, Yabe I, Niino M, Kikuchi S, Sasaki H. Cystatin C in cerebrospinal fluid as a biomarker of ALS. Neurosci Lett 2009, 452: 52\u201355.","journal-title":"Neurosci Lett"},{"key":"1730_CR254","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015133","volume":"5","author":"ME Wilson","year":"2010","unstructured":"Wilson ME, Boumaza I, Lacomis D, Bowser R. Cystatin C: A candidate biomarker for amyotrophic lateral sclerosis. PLoS One 2010, 5: e15133.","journal-title":"PLoS One"},{"key":"1730_CR255","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.7150\/ijbs.25711","volume":"14","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Yang M, Li F, Li M, Xu Z, Yang F, et al. Aberrant levels of cystatin C in amyotrophic lateral sclerosis: A systematic review and meta analysis. Int J Biol Sci 2018, 14: 1041\u20131053.","journal-title":"Int J Biol Sci"},{"key":"1730_CR256","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10072-023-06957-9","volume":"45","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Huo Y, Bai J, Li M, Wang H, Wang J, et al. Serum Cystatin C is a potential biomarker for predicting amyotrophic lateral sclerosis survival. Neurol Sci 2024, 45: 197\u2013201.","journal-title":"Neurol Sci"},{"key":"1730_CR257","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 2007, 39: 17\u201323.","journal-title":"Nat Genet"},{"key":"1730_CR258","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1001\/archneur.57.11.1579","volume":"57","author":"U Finckh","year":"2000","unstructured":"Finckh U. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol 2000, 57: 1579\u20131583.","journal-title":"Arch Neurol"},{"key":"1730_CR259","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0271678X211039997","volume":"42","author":"L Skukan","year":"2022","unstructured":"Skukan L, Brezak M, Ister R, Klimaschewski L, Vojta A, Zoldo\u0161 V, et al. Lentivirus- or AAV-mediated gene therapy interventions in ischemic stroke: A systematic review of preclinical in vivo studies. J Cereb Blood Flow Metab 2022, 42: 219\u2013236.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1730_CR260","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","volume":"403","author":"NA Hilkens","year":"2024","unstructured":"Hilkens NA, Casolla B, Leung TW, de Leeuw FE. Stroke. Lancet 2024, 403: 2820\u20132836.","journal-title":"Stroke. Lancet"},{"key":"1730_CR261","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.neurobiolaging.2009.08.013","volume":"32","author":"R Ghidoni","year":"2011","unstructured":"Ghidoni R, Paterlini A, Albertini V, Glionna M, Monti E, Schiaffonati L, et al. Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer\u2019s disease. Neurobiol Aging 2011, 32: 1435\u20131442.","journal-title":"Neurobiol Aging"},{"key":"1730_CR262","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 2018, 14: 133\u2013150.","journal-title":"Nat Rev Neurol"},{"key":"1730_CR263","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s40001-024-01987-1","volume":"29","author":"R Rahimi Darehbagh","year":"2024","unstructured":"Rahimi Darehbagh R, Seyedoshohadaei SA, Ramezani R, Rezaei N. Stem cell therapies for neurological disorders: Current progress, challenges, and future perspectives. Eur J Med Res 2024, 29: 386.","journal-title":"Eur J Med Res"},{"key":"1730_CR264","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/STROKEAHA.122.040578","volume":"54","author":"AV Andjelkovic","year":"2023","unstructured":"Andjelkovic AV, Situ M, Citalan-Madrid AF, Stamatovic SM, Xiang J, Keep RF. Blood-brain barrier dysfunction in normal aging and neurodegeneration: Mechanisms, impact, and treatments. Stroke 2023, 54: 661\u2013672.","journal-title":"Stroke"},{"key":"1730_CR265","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12035-025-05517-w","volume":"63","author":"F Goel","year":"2025","unstructured":"Goel F, Singh P, Rai SN, Yadav DK. Nrf2\/Keap1 signaling axis in the brain: Master regulator of oxidative stress in neurodegenerative and psychiatric disorders. Mol Neurobiol 2025, 63: 197.","journal-title":"Mol Neurobiol"},{"key":"1730_CR266","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12951-024-02681-4","volume":"22","author":"Z Nouri","year":"2024","unstructured":"Nouri Z, Barfar A, Perseh S, Motasadizadeh H, Maghsoudian S, Fatahi Y, et al. Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases. J Nanobiotechnology 2024, 22: 463.","journal-title":"J Nanobiotechnology"},{"key":"1730_CR267","doi-asserted-by":"publisher","first-page":"22752","DOI":"10.1021\/acsnano.4c06851","volume":"18","author":"J Lin","year":"2024","unstructured":"Lin J, Yu Z, Gao X. Advanced noninvasive strategies for the brain delivery of therapeutic proteins and peptides. ACS Nano 2024, 18: 22752\u201322779.","journal-title":"ACS Nano"},{"key":"1730_CR268","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1021\/acsnano.4c14675","volume":"19","author":"G Kong","year":"2025","unstructured":"Kong G, Liu J, Wang J, Yu X, Li C, Deng M, et al. Engineered extracellular vesicles modified by angiopep-2 peptide promote targeted repair of spinal cord injury and brain inflammation. ACS Nano 2025, 19: 4582\u20134600.","journal-title":"ACS Nano"},{"key":"1730_CR269","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307899120","volume":"120","author":"Z Cheng","year":"2023","unstructured":"Cheng Z, Zheng Y, Yang W, Sun H, Zhou F, Huang C, et al. Pathogenic bacteria exploit transferrin receptor transcytosis to penetrate the blood-brain barrier. Proc Natl Acad Sci U S A 2023, 120: e2307899120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1730_CR270","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41582-026-01209-8","volume":"22","author":"JCF Kwok","year":"2026","unstructured":"Kwok JCF, Dityatev A. Extracellular matrix remodelling in neurological diseases. Nat Rev Neurol 2026, 22: 366\u2013384.","journal-title":"Nat Rev Neurol"},{"key":"1730_CR271","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neuron.2016.11.013","volume":"93","author":"Z Padamsey","year":"2017","unstructured":"Padamsey Z, McGuinness L, Bardo SJ, Reinhart M, Tong R, Hedegaard A, et al. Activity-dependent exocytosis of lysosomes regulates the structural plasticity of dendritic spines. Neuron 2017, 93: 132\u2013146.","journal-title":"Neuron"},{"key":"1730_CR272","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2026.114920","volume":"457","author":"H Guo","year":"2026","unstructured":"Guo H, Peng X, Zhang X, Ruganzu JB, Wu X, Zhao M, et al. Insulin-like growth factor-1 enhances \u03b2-amyloid protein clearance in HMC3 microglia via low-density lipoprotein receptor-related protein 1-mediated pathway. Exp Cell Res 2026, 457: 114920.","journal-title":"Exp Cell Res"},{"key":"1730_CR273","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.3390\/biomedicines13123019","volume":"13","author":"F Di Matteo","year":"2025","unstructured":"Di Matteo F, Vietri M, D\u2019Alessio S, Ciaglia T, Vestuto EF, Pepe G, et al. Targeting cathepsins in neurodegeneration: Biochemical advances. Biomedicines 2025, 13: 3019.","journal-title":"Biomedicines"},{"key":"1730_CR274","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13024-025-00886-1","volume":"20","author":"D Balta","year":"2025","unstructured":"Balta D, Varghese A, Prieto Huarcaya S, Di Spiezio A, Marques ARA, Akda\u015f EY, et al. Recombinant cathepsins B and L promote \u03b1-synuclein clearance and restore lysosomal function in human and murine models with \u03b1-synuclein pathology. Mol Neurodegener 2025, 20: 95.","journal-title":"Mol Neurodegener"},{"key":"1730_CR275","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2026.118951","volume":"315","author":"M Czuba","year":"2026","unstructured":"Czuba M, Szafra\u0144ska K, Kolaczkowski M, Marcinkowska M. Targeting lysosomal dysfunction with small-molecule TRPML1 ligands: Therapeutic opportunities in lysosomal storage disorders, neurodegeneration and beyond. Eur J Med Chem 2026, 315: 118951.","journal-title":"Eur J Med Chem"},{"key":"1730_CR276","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/17460441.2026.2665791","volume":"21","author":"O Fardel","year":"2026","unstructured":"Fardel O, Mahfoudhi E, Launay L, Moreau A, Denizot C, Malno\u00eb D, et al. In vitro prediction of the immunogenicity of therapeutic proteins: State of the art and current challenges and perspectives. Expert Opin Drug Discov 2026, 21: 655\u2013673.","journal-title":"Expert Opin Drug Discov"},{"key":"1730_CR277","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1021\/acschemneuro.6c00245","volume":"17","author":"D Panchal","year":"2026","unstructured":"Panchal D, Solanki D, Solanki R, Yadav AK, Bhatia D, Yadav P. Biomaterials and nanoparticle-based therapeutics in neurodegenerative diseases: Bridging the gap between innovation and translation. ACS Chem Neurosci 2026, 17: 1824\u20131869.","journal-title":"ACS Chem Neurosci"},{"key":"1730_CR278","doi-asserted-by":"publisher","first-page":"2314128","DOI":"10.1155\/2020\/2314128","volume":"2020","author":"M Provenzano","year":"2020","unstructured":"Provenzano M, Andreucci M, De Nicola L, Garofalo C, Battaglia Y, Borrelli S, et al. The role of prognostic and predictive biomarkers for assessing cardiovascular risk in chronic kidney disease patients. Biomed Res Int 2020, 2020: 2314128.","journal-title":"Biomed Res Int"},{"key":"1730_CR279","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2026.115815","volume":"403","author":"C Hoyer-Kimura","year":"2026","unstructured":"Hoyer-Kimura C, Hay M. Neurovascular unit dysfunction in vascular cognitive impairment: Mechanisms, biomarkers, and translational strategies. Exp Neurol 2026, 403: 115815.","journal-title":"Exp Neurol"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01730-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-026-01730-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01730-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:02:50Z","timestamp":1791878570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-026-01730-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":279,"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1007\/s12264-026-01730-2","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}